Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,Source_Sheet,Source_DB
Carbohydrate metabolism,5/235,2.1463678707885583E-10,6.2484548073962406E-9,0,0,98825,2200049.4510730691,PFKFB2;G6PC;PC;PCK1;FBP1,Gluconeogenesis,bioplanet
Glucose metabolism,4/61,3.9052842546226504E-10,6.2484548073962406E-9,0,0,1399.1578947368421,30310.685535038476,PFKFB2;PC;PCK1;FBP1,Gluconeogenesis,bioplanet
Glycolysis and gluconeogenesis,4/75,9.0908281149451864E-10,9.6968833226081977E-9,0,0,1122.4788732394366,23368.42174809541,G6PC;PC;PCK1;FBP1,Gluconeogenesis,bioplanet
Gluconeogenesis,3/31,3.3642024187275298E-8,2.6913619349820238E-7,0,0,1069.6607142857142,18406.17586435096,PC;PCK1;FBP1,Gluconeogenesis,bioplanet
Metabolism,5/1615,3.4135429707695216E-6,2.184667501292494E-5,0,0,91925,1157129.8206895434,PFKFB2;G6PC;PC;PCK1;FBP1,Gluconeogenesis,bioplanet
Insulin signaling pathway,3/277,2.5745660187386585E-5,1.2781834767008142E-4,0,0,107.96167883211679,1140.857454848983,G6PC;PCK1;FBP1,Gluconeogenesis,bioplanet
Fructose and mannose metabolism,2/34,2.796026355283031E-5,1.2781834767008142E-4,0,0,415.89583333333331,4360.5539462830129,PFKFB2;FBP1,Gluconeogenesis,bioplanet
Tricarboxylic acid (TCA) cycle,2/39,3.6913092111424042E-5,1.4765236844569617E-4,0,0,359.60360360360363,3670.4539413007556,PC;PCK1,Gluconeogenesis,bioplanet
HNF3B pathway,2/45,4.9287607457002442E-5,1.7524482651378644E-4,0,0,309.33333333333331,3067.9178504329798,G6PC;PCK1,Gluconeogenesis,bioplanet
Pyruvate metabolism,2/52,6.5969445889092458E-5,1.9941714032615016E-4,0,0,265.93333333333334,2559.9590632869204,PC;PCK1,Gluconeogenesis,bioplanet
PI3K pathway,2/53,6.8549641987114115E-5,1.9941714032615016E-4,0,0,260.70588235294116,2499.635583784046,G6PC;PCK1,Gluconeogenesis,bioplanet
Adipocytokine signaling pathway,2/67,1.098341891953128E-4,2.9289117118750079E-4,0,0,204.41025641025641,1863.5140133125917,G6PC;PCK1,Gluconeogenesis,bioplanet
Abacavir metabolism,1/5,1.2494733811348967E-3,3.0756267843320534E-3,0,0,1249.4375,8352.5310582869151,PCK1,Gluconeogenesis,bioplanet
Shuttle for transfer of acetyl groups from mitochondria to the cytosol,1/8,1.998563431658992E-3,4.5681449866491241E-3,0,0,713.85714285714289,4436.855317641398,PC,Gluconeogenesis,bioplanet
Abacavir transport and metabolism,1/10,2.4977078641967437E-3,5.3284434436197195E-3,0,0,555.16666666666663,3326.7706415121643,PCK1,Gluconeogenesis,bioplanet
Alanine and aspartate metabolism,1/12,2.9966530298936489E-3,5.9933060597872978E-3,0,0,454.18181818181819,2638.9141192765878,PC,Gluconeogenesis,bioplanet
Proximal tubule bicarbonate reclamation,1/23,5.7372891133286473E-3,1.0258879830234892E-2,0,0,226.96590909090909,1171.3185051583378,PCK1,Gluconeogenesis,bioplanet
Fatty acid biosynthesis,1/25,6.2349390704731535E-3,1.0258879830234892E-2,0,0,208.03125,1056.2966607689368,PC,Gluconeogenesis,bioplanet
Galactose metabolism,1/26,6.483689369798885E-3,1.0258879830234892E-2,0,0,199.7,1006.1815770136444,G6PC,Gluconeogenesis,bioplanet
Pentose phosphate pathway,1/27,6.7323898885916483E-3,1.0258879830234892E-2,0,0,192.00961538461539,960.20650187087131,FBP1,Gluconeogenesis,bioplanet
Glycolysis,1/27,6.7323898885916483E-3,1.0258879830234892E-2,0,0,192.00961538461539,960.20650187087131,PFKFB2,Gluconeogenesis,bioplanet
Hexose transport,1/42,1.045692833454581E-2,1.5210077577521179E-2,0,0,121.67073170731707,554.87821872397762,G6PC,Gluconeogenesis,bioplanet
FoxO family signaling,1/49,1.2191219830698688E-2,1.6961697155754695E-2,0,0,103.890625,457.85006440393749,G6PC,Gluconeogenesis,bioplanet
Starch and sucrose metabolism,1/53,1.3181151581290242E-2,1.7574868775053654E-2,0,0,95.879807692307693,415.06055993268222,G6PC,Gluconeogenesis,bioplanet
PPAR signaling pathway,1/69,1.7132947269309973E-2,2.1930172504716766E-2,0,0,73.26102941176471,297.93443263412689,PCK1,Gluconeogenesis,bioplanet
Transcriptional regulation of white adipocyte differentiation,1/77,1.9104092772120228E-2,2.3512729565686435E-2,0,0,65.52302631578948,259.33048567400635,PCK1,Gluconeogenesis,bioplanet
ATM-dependent DNA damage response,1/82,2.0334452124159075E-2,2.4100091406410753E-2,0,0,61.462962962962962,239.42520346643704,G6PC,Gluconeogenesis,bioplanet
Adipogenesis,1/133,3.2813749721153695E-2,3.7501428252747077E-2,0,0,37.61931818181818,128.54173618163773,PCK1,Gluconeogenesis,bioplanet
SLC-mediated transmembrane transport,1/251,6.1200327015790978E-2,6.7531395327769361E-2,0,0,19.745000000000001,55.159686221405977,G6PC,Gluconeogenesis,bioplanet
FSH regulation of apoptosis,1/263,6.4049339468301159E-2,6.8319295432854574E-2,0,0,18.829198473282442,51.744549762815979,PCK1,Gluconeogenesis,bioplanet
Developmental biology,1/420,0.10069097383003282,0.10344367348209985,0,0,11.680190930787589,26.814204012447785,PCK1,Gluconeogenesis,bioplanet
Transmembrane transport of small molecules,1/432,0.10344367348209985,0.10344367348209985,0,0,11.348027842227378,25.745588873363179,G6PC,Gluconeogenesis,bioplanet
Glycolysis and gluconeogenesis,16/75,4.6381166852004003E-39,2.2726771757481962E-37,0,0,5403.1186440677966,476914.42706907785,TPI1;PKLR;ENO1;ENO2;HK2;HK1;PFKL;PKM;PGK1;PGAM4;PGK2;ALDOB;ALDOA;PFKM;GAPDH;PGM1,Glycolysis,bioplanet
Glycolysis,11/27,3.1333078720506259E-29,7.6766042865240335E-28,0,0,2287.8854166666665,150160.5053959935,PFKL;TPI1;PKLR;PGK1;ENO1;ALDOB;ENO2;ALDOA;PFKM;GAPDH;HK1,Glycolysis,bioplanet
Glucose metabolism,11/61,9.9600104992742193E-25,1.6268017148814556E-23,0,0,730.87666666666667,40392.66581848239,PFKL;TPI1;PKLR;PGK1;ENO1;ALDOB;ENO2;ALDOA;PFKM;GAPDH;PGM1,Glycolysis,bioplanet
Carbohydrate metabolism,13/235,1.3287791750207431E-22,1.6277544894004103E-21,0,0,289.29391891891891,14572.490169279799,TPI1;PKLR;ENO1;ENO2;HK2;HK1;PFKL;PGK1;ALDOB;ALDOA;PFKM;GAPDH;PGM1,Glycolysis,bioplanet
Metabolism,16/1615,4.7936581487008003E-17,4.6977849857267845E-16,0,0,183.95497185741087,6912.4121001493386,TPI1;PKLR;ENO1;ENO2;HK2;HK1;PFKL;PKM;PGK1;PGAM4;PGK2;ALDOB;ALDOA;PFKM;GAPDH;PGM1,Glycolysis,bioplanet
Gluconeogenesis,7/31,1.9934330232301255E-16,1.5051878279702212E-15,0,0,582.13750000000005,21045.14569304619,TPI1;PGK1;ENO1;ALDOB;ENO2;ALDOA;GAPDH,Glycolysis,bioplanet
HIF-1 transcriptional activity in hypoxia,8/66,2.1502683256717446E-16,1.5051878279702212E-15,0,0,305.36398467432952,11016.240526505262,PFKL;PKM;PGK1;ENO1;ALDOA;HK2;PGM1;HK1,Glycolysis,bioplanet
Fructose and mannose metabolism,7/34,4.0729311491749796E-16,2.494670328869675E-15,0,0,517.37777777777774,18334.315567942351,PFKL;TPI1;ALDOB;ALDOA;PFKM;HK2;HK1,Glycolysis,bioplanet
Galactose metabolism,5/26,1.5107764196333078E-11,8.2253382846702322E-11,0,0,396.07142857142856,9868.4413792308442,PFKL;PFKM;HK2;PGM1;HK1,Glycolysis,bioplanet
Pentose phosphate pathway,5/27,1.8532157768857895E-11,9.0807573067403687E-11,0,0,378.04924242424244,9342.1690089020194,PFKL;ALDOB;ALDOA;PFKM;PGM1,Glycolysis,bioplanet
Type 2 diabetes mellitus,4/50,8.0285871100463604E-8,3.576370621747924E-7,0,0,133.35785953177256,2178.7569920435021,PKM;PKLR;HK2;HK1,Glycolysis,bioplanet
Starch and sucrose metabolism,4/53,1.0192400585928009E-7,4.1618969059206032E-7,0,0,125.17425431711146,2015.1851196746893,HK2;PGM2L1;PGM1;HK1,Glycolysis,bioplanet
Insulin signaling pathway,5/277,2.6539676267193902E-6,1.0003416439173085E-5,0,0,30.194546568627452,387.68151647975787,PFKL;PKLR;PFKM;HK2;HK1,Glycolysis,bioplanet
Amino sugar and nucleotide sugar metabolism,3/45,7.079575915355642E-6,2.4778515703744749E-5,0,0,101.73979591836735,1206.460671039616,HK2;PGM1;HK1,Glycolysis,bioplanet
Myc active pathway,3/85,4.8253836016492294E-5,1.5762919765387483E-4,0,0,52.006097560975611,516.89043585451941,ENO1;PFKM;GAPDH,Glycolysis,bioplanet
Downregulation of MTA-3 in ER-negative breast tumors,2/18,1.0321185160705684E-4,3.1608629554661158E-4,0,0,166.39166666666668,1527.2636618368022,ALDOA;GAPDH,Glycolysis,bioplanet
Phosphoinositides and their downstream targets,2/25,2.0167031602328324E-4,5.8128502853769875E-4,0,0,115.71014492753623,984.56330900828823,PFKL;PFKM,Glycolysis,bioplanet
Glucuronidation,2/27,2.357187816910066E-4,6.4167890571440692E-4,0,0,106.44266666666667,889.10187063750948,PGM1;HK1,Glycolysis,bioplanet
Purine metabolism,3/164,3.3828247884827486E-4,8.7241270860870886E-4,0,0,26.382431233362912,210.83860979752092,PKM;PKLR;PGM1,Glycolysis,bioplanet
Hexose transport,2/42,5.7390151341791954E-4,1.4060587078739029E-3,0,0,66.476666666666674,496.11887036156423,HK2;HK1,Glycolysis,bioplanet
HNF3B pathway,2/45,6.5889897816177813E-4,1.537430949044149E-3,0,0,61.829457364341089,452.89708588387782,PKLR;ALDOB,Glycolysis,bioplanet
Pyruvate metabolism,2/52,8.7944607288811209E-4,1.9587662532507947E-3,0,0,53.154666666666664,374.0078389317888,PKM;PKLR,Glycolysis,bioplanet
RNA degradation,2/59,1.1308314717929646E-3,2.4091627007763162E-3,0,0,46.610526315789471,316.24319688035297,ENO1;ENO2,Glycolysis,bioplanet
T cell receptor regulation of apoptosis,4/603,1.423644932353552E-3,2.9066084035551682E-3,0,0,9.9571080005136761,65.264211318323078,PKLR;PGK1;ENO1;GAPDH,Glycolysis,bioplanet
ChREBP activates metabolic gene expression,1/8,6.7809060200976099E-3,1.2779399807107034E-2,0,0,178.35714285714286,890.65217521593831,PKLR,Glycolysis,bioplanet
Glycogen biosynthesis,1/8,6.7809060200976099E-3,1.2779399807107034E-2,0,0,178.35714285714286,890.65217521593831,PGM1,Glycolysis,bioplanet
Glycogen breakdown (glycogenolysis),1/14,1.183818865932929E-2,2.1484120159523529E-2,0,0,96.009615384615387,425.93942395331476,PGM1,Glycolysis,bioplanet
Gene expression regulation in pancreatic beta cells,1/20,1.6871234817272356E-2,2.9524660930226623E-2,0,0,65.671052631578945,268.07877156039848,PKLR,Glycolysis,bioplanet
ChREBP regulation by carbohydrates and cAMP,1/21,1.770772695128657E-2,2.9919952434932482E-2,0,0,62.384374999999999,251.6432336564321,PKLR,Glycolysis,bioplanet
SLC-mediated transmembrane transport,2/251,1.8845083220295999E-2,3.0780302593150132E-2,0,0,10.567068273092369,41.967145844066721,HK2;HK1,Glycolysis,bioplanet
FSH regulation of apoptosis,2/263,2.0570870769650317E-2,3.2228222607194976E-2,0,0,10.075095785440613,39.130455404332182,PGK1;HK2,Glycolysis,bioplanet
Maturity onset diabetes of the young,1/25,2.1047002518984472E-2,3.2228222607194976E-2,0,0,51.9765625,200.68135849118187,PKLR,Glycolysis,bioplanet
Pancreatic beta-cell development regulation,1/32,2.6865043358944445E-2,3.882073229441621E-2,0,0,40.225806451612904,145.49389961403264,PKLR,Glycolysis,bioplanet
Oncostatin M,2/311,2.8104246992205362E-2,3.882073229441621E-2,0,0,8.4893203883495154,30.322448086028903,PGK1;HK2,Glycolysis,bioplanet
Fatty acid beta oxidation,1/34,2.8521354338754766E-2,3.882073229441621E-2,0,0,37.784090909090907,134.40187279306201,TPI1,Glycolysis,bioplanet
HIF-2-alpha transcription factor network,1/34,2.8521354338754766E-2,3.882073229441621E-2,0,0,37.784090909090907,134.40187279306201,PGK1,Glycolysis,bioplanet
Glycogen metabolism,1/36,3.0175011976485019E-2,3.9961502347236916E-2,0,0,35.621428571428574,124.70139957851625,PGM1,Glycolysis,bioplanet
Inositol phosphate metabolism,1/57,4.7379217721655043E-2,6.1094254430555189E-2,0,0,22.239955357142858,67.822336044851085,TPI1,Glycolysis,bioplanet
Transmembrane transport of small molecules,2/432,5.1120740956050008E-2,6.4228623252473083E-2,0,0,6.0629457364341084,18.028563084594005,HK2;HK1,Glycolysis,bioplanet
Response to elevated platelet cytosolic calcium,1/83,6.8281787330545546E-2,8.3645189479918294E-2,0,0,15.168445121951219,40.713808681356575,ALDOA,Glycolysis,bioplanet
Notch signaling pathway,1/121,9.8056538362798595E-2,0.1171895214579788,0,0,10.3453125,24.02399894731515,ENO1,Glycolysis,bioplanet
Integration of energy metabolism,1/125,0.10113808374787076,0.11799443103918256,0,0,10.009576612903226,22.934627892175829,PKLR,Glycolysis,bioplanet
Interleukin-5 regulation of apoptosis,1/144,0.11564058767870697,0.1317764836338754,0,0,8.6713286713286717,18.706382287067274,ENO1,Glycolysis,bioplanet
Alzheimer's disease,1/169,0.13438749659312352,0.14965880302416026,0,0,7.3716517857142856,14.79511070365777,GAPDH,Glycolysis,bioplanet
Interleukin-2 signaling pathway,2/847,0.16049591335959268,0.1712091431169718,0,0,3.0198027613412228,5.5246892864616717,TPI1;GAPDH,Glycolysis,bioplanet
"Platelet activation, signaling and aggregation",1/205,0.16072695068123882,0.1712091431169718,0,0,6.0597426470588234,11.077502318716135,ALDOA,Glycolysis,bioplanet
Developmental biology,1/420,0.30298408613866784,0.31587702597435585,0,0,2.9182577565632459,3.4846186185473891,PKLR,Glycolysis,bioplanet
Hemostasis pathway,1/468,0.33148095716029624,0.33838681043446905,0,0,2.6118843683083512,2.8840033204376518,ALDOA,Glycolysis,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.38575470152939717,0.38575470152939717,0,0,2.1519281914893615,2.0498269452957278,PKM,Glycolysis,bioplanet
Pyruvate metabolism and citric acid (TCA) cycle,4/40,1.7150492788048153E-9,8.4037414661435951E-8,0,0,443.44444444444446,8950.4046305302963,LDHB;LDHA;SLC16A1;SLC16A3,Lactate-Shuttle,bioplanet
Pyruvate metabolism,4/52,5.0684015291316328E-9,1.24175837463725E-7,0,0,332.38333333333333,6348.6015547697461,LDHB;LDHA;SLC16A1;SLC16A3,Lactate-Shuttle,bioplanet
Glycolysis and gluconeogenesis,4/75,2.265107375482483E-8,3.6996753799547222E-7,0,0,224.45070422535213,3951.0188947443371,LDHB;LDHA;SLC2A1;SLC2A3,Lactate-Shuttle,bioplanet
SLC-mediated transmembrane transport,5/251,3.6177841133737576E-8,4.4317855388828533E-7,0,0,100.33028455284553,1719.1412689326651,SLC16A1;SLC2A1;SLC1A3;SLC2A3;SLC16A3,Lactate-Shuttle,bioplanet
"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds",4/96,6.1648658725022194E-8,6.0415685550521752E-7,0,0,173.03478260869565,2872.6913393600644,SLC16A1;SLC2A1;SLC2A3;SLC16A3,Lactate-Shuttle,bioplanet
Tricarboxylic acid (TCA) cycle and respiratory electron transport,4/117,1.3700583364722691E-7,1.1188809747856864E-6,0,0,140.729203539823,2223.9777065403487,LDHB;LDHA;SLC16A1;SLC16A3,Lactate-Shuttle,bioplanet
Transmembrane transport of small molecules,5/432,5.3895646331766106E-7,3.7726952432236274E-6,0,0,57.27166276346604,826.63804951064014,SLC16A1;SLC2A1;SLC1A3;SLC2A3;SLC16A3,Lactate-Shuttle,bioplanet
Vitamin C (ascorbate) metabolism,2/8,5.0328413188770481E-6,3.0826153078121921E-5,0,0,951.66666666666663,11609.882108963659,SLC2A1;SLC2A3,Lactate-Shuttle,bioplanet
Vitamin C in the brain,2/11,9.8790937525538598E-6,5.2796026878810003E-5,0,0,634.34920634920638,7310.9315524211261,SLC2A1;SLC2A3,Lactate-Shuttle,bioplanet
Bile salt and organic anion SLC transporters,2/12,1.1852169299324696E-5,5.2796026878810003E-5,0,0,570.88571428571424,6475.556453852173,SLC16A1;SLC16A3,Lactate-Shuttle,bioplanet
Facilitative sodium-independent glucose transporters,2/12,1.1852169299324696E-5,5.2796026878810003E-5,0,0,570.88571428571424,6475.556453852173,SLC2A1;SLC2A3,Lactate-Shuttle,bioplanet
Amino acid biosynthesis and interconversion (transamination),2/16,2.1529423708926259E-5,8.791181347811555E-5,0,0,407.69387755102042,4381.1151062519093,GLUL;GLS,Lactate-Shuttle,bioplanet
Nitrogen metabolism,2/23,4.5317428132053118E-5,1.7081184449773868E-4,0,0,271.70068027210885,2717.5009916130916,GLUL;GLS,Lactate-Shuttle,bioplanet
Basigin interactions,2/25,5.3711085527719463E-5,1.8798879934701812E-4,0,0,248.0496894409938,2438.7975447246135,SLC16A1;SLC16A3,Lactate-Shuttle,bioplanet
Transmission across chemical synapses,3/190,6.7965432511103664E-5,2.220204128696053E-4,0,0,52.951871657754012,508.15323617408029,SLC1A3;GLUL;GLS,Lactate-Shuttle,bioplanet
"Alanine, aspartate and glutamate metabolism",2/32,8.8657742357842911E-5,2.7151433597089389E-4,0,0,190.10476190476192,1773.8156714265488,GLUL;GLS,Lactate-Shuttle,bioplanet
Propanoate metabolism,2/33,9.4355619188798664E-5,2.7196619648536086E-4,0,0,183.963133640553,1705.0512168868192,LDHB;LDHA,Lactate-Shuttle,bioplanet
Cysteine and methionine metabolism,2/34,1.0022949748932253E-4,2.7284696538760025E-4,0,0,178.20535714285714,1640.9234871537965,LDHB;LDHA,Lactate-Shuttle,bioplanet
Hexose transport,2/42,1.5354169033610977E-4,3.9597593823523046E-4,0,0,142.50714285714287,1251.4319514828514,SLC2A1;SLC2A3,Lactate-Shuttle,bioplanet
Neuronal system,3/283,2.2106407720623084E-4,5.2941831234093646E-4,0,0,35.198214285714286,296.26540960330499,SLC1A3;GLUL;GLS,Lactate-Shuttle,bioplanet
Metabolism of vitamins and cofactors,2/51,2.2689356243182991E-4,5.2941831234093646E-4,0,0,116.27988338192419,975.7079361806791,SLC2A1;SLC2A3,Lactate-Shuttle,bioplanet
Arginine and proline metabolism,2/54,2.5447657793138006E-4,5.6678874175625552E-4,0,0,109.55494505494505,906.70978434626943,GLUL;GLS,Lactate-Shuttle,bioplanet
HIF-1 transcriptional activity in hypoxia,2/66,3.8038198335644852E-4,8.1037900802025998E-4,0,0,88.959821428571431,700.49939906456052,LDHA;SLC2A1,Lactate-Shuttle,bioplanet
Myc active pathway,2/85,6.3028283688298904E-4,1.2868274586361026E-3,0,0,68.53012048192771,505.02188772388456,LDHA;SLC2A1,Lactate-Shuttle,bioplanet
Cell surface interactions at the vascular wall,2/94,7.7007991687957369E-4,1.5093566370839645E-3,0,0,61.798136645962735,443.03184647404476,SLC16A1;SLC16A3,Lactate-Shuttle,bioplanet
Kit receptor transcriptional targets,1/5,2.24816055240216E-3,4.2369179641425321E-3,0,0,624.59375,3808.5496634307242,SLC2A1,Lactate-Shuttle,bioplanet
Amino acid metabolism,2/195,3.2547398103224814E-3,5.9067500261408001E-3,0,0,29.308660251665433,167.8695410270378,GLUL;GLS,Lactate-Shuttle,bioplanet
Metabolism,4/1615,3.833860410662531E-3,6.7092557186594296E-3,0,0,9.1272501551831162,50.782952370374986,LDHB;LDHA;GLUL;GLS,Lactate-Shuttle,bioplanet
Carbohydrate metabolism,2/235,4.687090407192466E-3,7.9195665500838217E-3,0,0,24.228080931943595,129.93382361053654,SLC2A1;SLC2A3,Lactate-Shuttle,bioplanet
Interleukin-2 signaling pathway,3/847,5.2480752354462186E-3,8.5718562178954908E-3,0,0,11.343009478672986,59.549596172411078,LDHB;SLC2A3;GLS,Lactate-Shuttle,bioplanet
Hypoxia-inducible factor in the cardivascular system,1/16,7.178349711373001E-3,1.0991847995539908E-2,0,0,166.46666666666667,821.79362410534554,LDHA,Lactate-Shuttle,bioplanet
Glutamate neurotransmitter release cycle,1/16,7.178349711373001E-3,1.0991847995539908E-2,0,0,166.46666666666667,821.79362410534554,GLS,Lactate-Shuttle,bioplanet
Oncostatin M,2/311,8.0727839448993272E-3,1.1986861009092941E-2,0,0,18.198797965788255,87.7046823335738,LDHA;SLC16A3,Lactate-Shuttle,bioplanet
Proximal tubule bicarbonate reclamation,1/23,1.0304464378507131E-2,1.48505516043191E-2,0,0,113.46022727272727,519.10074055447171,GLS,Lactate-Shuttle,bioplanet
HIF-2-alpha transcription factor network,1/34,1.519926045554118E-2,2.127896463775765E-2,0,0,75.598484848484844,316.49369990079617,SLC2A1,Lactate-Shuttle,bioplanet
Neurotransmitter release cycle,1/36,1.6086908285246115E-2,2.189606961047388E-2,0,0,71.271428571428572,294.33314563493832,GLS,Lactate-Shuttle,bioplanet
Hemostasis pathway,2/468,1.7640279347373927E-2,2.3361451027603307E-2,0,0,11.971183323114653,48.334495348716601,SLC16A1;SLC16A3,Lactate-Shuttle,bioplanet
Amino acid and oligopeptide SLC transporters,1/49,2.1839307484116888E-2,2.8161212282150724E-2,0,0,51.934895833333336,198.60131834764672,SLC1A3,Lactate-Shuttle,bioplanet
Adipocytokine signaling pathway,1/67,2.9754818181739934E-2,3.7384258741160428E-2,0,0,37.736742424242422,132.63575146396252,SLC2A1,Lactate-Shuttle,bioplanet
Renal cell carcinoma,1/70,3.1068520170340619E-2,3.8058937208667258E-2,0,0,36.090579710144929,125.29061959707016,SLC2A1,Lactate-Shuttle,bioplanet
Transport of inorganic cations/anions and amino acids/oligopeptides,1/95,4.1954702006136844E-2,5.0140985324407444E-2,0,0,26.458776595744681,83.905140102139669,SLC1A3,Lactate-Shuttle,bioplanet
TNF-alpha signaling pathway,1/101,4.4551152729863527E-2,5.1976344851507449E-2,0,0,24.86375,77.354041535408541,GLUL,Lactate-Shuttle,bioplanet
Prolactin regulation of apoptosis,1/118,5.1873830207626925E-2,5.9112039073807431E-2,0,0,21.232905982905983,62.826912896138587,LDHB,Lactate-Shuttle,bioplanet
Integration of energy metabolism,1/125,5.4874521634060522E-2,6.1110262728840119E-2,0,0,20.027217741935484,58.13312760621578,SLC2A1,Lactate-Shuttle,bioplanet
Insulin signaling pathway,1/277,0.117984947813912,0.12847249873070415,0,0,8.9288949275362324,19.082818377413854,SLC2A1,Lactate-Shuttle,bioplanet
Pathways in cancer,1/325,0.13712085421734307,0.14606351862282199,0,0,7.5875771604938276,15.075700869970223,SLC2A1,Lactate-Shuttle,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.22737553151715231,0.23705108604979711,0,0,4.3056294326241131,6.3772929565534495,SLC2A1,Lactate-Shuttle,bioplanet
T cell receptor regulation of apoptosis,1/603,0.24086838394878349,0.24588647528104979,0,0,4.0259551495016614,5.7309657526748783,SLC16A1,Lactate-Shuttle,bioplanet
Disease,1/674,0.26551856783167127,0.26551856783167127,0,0,3.5880386329866272,4.7579922034739033,LDHB,Lactate-Shuttle,bioplanet
Neuroactive ligand-receptor interaction,26/272,8.7194631295294778E-50,3.4005906205164965E-48,0,0,512928,57942243.165271066,GRIA1;GRIA2;GRIK5;GRIK3;GRIK4;GRIK1;GRIK2;GRM1;GRM3;GRM2;GRM5;GRIN2A;GRM4;GRM7;GRM6;GRM8;GRIA3;GRIA4;GRID2;GRID1;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A,Glutamate-Receptors,bioplanet
Hypothetical network for drug addiction,11/32,1.9173735750054368E-25,3.7388784712606016E-24,0,0,696.7714285714286,39655.819851374486,GRIA1;GRIA2;GRM5;GRIN2A;GRIN2C;GRIN2B;GRIA3;GRM1;GRIN2D;GRIN1;GRIA4,Glutamate-Receptors,bioplanet
"Unblocking of NMDA receptor, glutamate binding and activation",9/17,5.3535539233104623E-23,6.9596201003036014E-22,0,0,1321.2794117647059,67757.449804001808,GRIA1;GRIA2;GRIN2A;GRIN2C;GRIN2B;GRIA3;GRIN2D;GRIN1;GRIA4,Glutamate-Receptors,bioplanet
Transmission across chemical synapses,14/190,2.620244444144339E-22,2.5547383330407304E-21,0,0,131.23674242424244,6521.6267651263352,GRIA1;GRIA2;GRIK5;GRIK3;GRIK4;GRIK1;GRIK2;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN2A;GRIA3;GRIA4,Glutamate-Receptors,bioplanet
Neuronal system,14/283,7.7488064711606996E-20,6.0440690475053458E-19,0,0,85.461586121437421,3760.6655686693007,GRIA1;GRIA2;GRIK5;GRIK3;GRIK4;GRIK1;GRIK2;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN2A;GRIA3;GRIA4,Glutamate-Receptors,bioplanet
Class C GPCRs (metabotropic glutamate and pheromone receptors),8/19,1.8443930641781294E-19,1.1988554917157841E-18,0,0,806.58585858585855,34793.667166047155,GRM3;GRM2;GRM5;GRM4;GRM7;GRM6;GRM8;GRM1,Glutamate-Receptors,bioplanet
Activation of NMDA receptor upon glutamate binding and postsynaptic events,9/37,2.6989910036156474E-19,1.5037235591572892E-18,0,0,377.13025210084032,16124.671104737467,GRIA1;GRIA2;GRIN2A;GRIN2C;GRIN2B;GRIA3;GRIN2D;GRIN1;GRIA4,Glutamate-Receptors,bioplanet
Long-term potentiation,9/70,1.375994613259361E-16,6.7079737396393854E-16,0,0,172.82256509161041,6311.8576362408767,GRIA1;GRIA2;GRM5;GRIN2A;GRIN2C;GRIN2B;GRM1;GRIN2D;GRIN1,Glutamate-Receptors,bioplanet
Amyotrophic lateral sclerosis (ALS),7/53,3.844980276133327E-13,1.6661581196577749E-12,0,0,159.60640732265446,4562.6424677143386,GRIA1;GRIA2;GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Glutamate-Receptors,bioplanet
Activation of calcium-permeable kainate receptor,5/10,6.1898153694426078E-13,2.4140279940826169E-12,0,0,950.90476190476193,26730.599393742075,GRIK5;GRIK3;GRIK4;GRIK1;GRIK2,Glutamate-Receptors,bioplanet
Ras activation upon calcium influx through NMDA receptor,5/19,2.8340049104748364E-11,1.0047835591683511E-10,0,0,339.45578231292518,8244.276074377045,GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Glutamate-Receptors,bioplanet
Nitric oxide signaling pathway,5/22,6.4014642778793595E-11,2.0804758903107918E-10,0,0,279.50980392156862,6560.6287564142895,GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Glutamate-Receptors,bioplanet
Long-term depression,6/70,3.2161437385397537E-10,9.5830698292586724E-10,0,0,93.328125,2039.9351605613749,GRIA1;GRIA2;GRID2;GRM5;GRIA3;GRM1,Glutamate-Receptors,bioplanet
Activation of kainate receptors upon glutamate binding,5/30,3.4400763489646516E-10,9.5830698292586724E-10,0,0,189.99047619047619,4139.9603530116037,GRIK5;GRIK3;GRIK4;GRIK1;GRIK2,Glutamate-Receptors,bioplanet
GluR2-containing AMPA receptor trafficking,4/16,4.0389400031251286E-9,1.0501244008125335E-8,0,0,302.45454545454544,5845.6247624574698,GRIA1;GRIA2;GRIA3;GRIA4,Glutamate-Receptors,bioplanet
GPCR ligand binding,8/410,3.2940379850737321E-8,8.0292175886172224E-8,0,0,21.638474295190711,372.79989509877635,GRM3;GRM2;GRM5;GRM4;GRM7;GRM6;GRM8;GRM1,Glutamate-Receptors,bioplanet
Glutamate binding and activation of AMPA receptors and synaptic plasticity,4/30,6.007467015815436E-8,1.3781836095105998E-7,0,0,139.49650349650349,2319.502878911991,GRIA1;GRIA2;GRIA3;GRIA4,Glutamate-Receptors,bioplanet
Calcium signaling pathway,6/178,9.0693623211320506E-8,1.9650285029119442E-7,0,0,34.538372093023256,560.06660158148281,GRM5;GRIN2A;GRIN2C;GRM1;GRIN2D;GRIN1,Glutamate-Receptors,bioplanet
Alzheimer's disease,5/169,2.3130062272197677E-6,4.747749624293208E-6,0,0,28.760162601626018,373.21955107043124,GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Glutamate-Receptors,bioplanet
Signaling by GPCR,8/977,2.2393671930501098E-5,4.366766026447714E-5,0,0,8.7168902648778808,93.32940917827851,GRM3;GRM2;GRM5;GRM4;GRM7;GRM6;GRM8;GRM1,Glutamate-Receptors,bioplanet
Signal transduction,8/1020,3.0537143500904826E-5,5.6711837930251823E-5,0,0,8.3276240667545007,86.578699858576243,GRM3;GRM2;GRM5;GRM4;GRM7;GRM6;GRM8;GRM1,Glutamate-Receptors,bioplanet
Huntington's disease,4/184,8.8468542667558412E-5,1.5683059836521718E-4,0,0,19.993939393939392,186.60070757522922,GRM5;GRIN2B;GRM1;GRIN1,Glutamate-Receptors,bioplanet
Reelin signaling pathway,2/29,6.4567196496487819E-4,1.0948350710274022E-3,0,0,61.564814814814817,452.20704611326545,GRIN2A;GRIN2B,Glutamate-Receptors,bioplanet
"Non-class A, B, C GPCRs",2/86,5.5543621266744211E-3,9.0258384558459352E-3,0,0,19.732142857142858,102.47240569174454,GRM8;GRM1,Glutamate-Receptors,bioplanet
Gap junction pathway,2/90,6.0668977190373079E-3,9.4643604416982004E-3,0,0,18.831439393939394,96.132763518396445,GRM5;GRM1,Glutamate-Receptors,bioplanet
FOSB gene expression and drug abuse,1/5,6.483689369798885E-3,9.7255340546983267E-3,0,0,199.7,1006.1815770136444,GRIA2,Glutamate-Receptors,bioplanet
Systemic lupus erythematosus,2/139,1.3973961266051086E-2,1.9793636121470545E-2,0,0,12.066301703163017,51.529860462892621,GRIN2A;GRIN2B,Glutamate-Receptors,bioplanet
Erythropoietin-mediated neuroprotection through NF-kB,1/11,1.4210815676953212E-2,1.9793636121470545E-2,0,0,79.855999999999995,339.68761467350572,GRIN1,Glutamate-Receptors,bioplanet
Synaptic proteins at the synaptic junction,1/17,2.188015065344143E-2,2.9425030189110888E-2,0,0,49.895000000000003,190.70744238188936,GRIN1,Glutamate-Receptors,bioplanet
Presynaptic function of kainate receptors,1/21,2.6961136138080617E-2,3.50494769795048E-2,0,0,39.908000000000001,144.2019250738276,GRIK3,Glutamate-Receptors,bioplanet
Ck1/Cdk5 regulation by type 1 glutamate receptors,1/25,3.2016739803822636E-2,4.0279124269325249E-2,0,0,33.25,114.42975510355667,GRM1,Glutamate-Receptors,bioplanet
ADP signalling through P2Y purinoceptor 12,1/27,3.4535061360654686E-2,4.2089606033297901E-2,0,0,30.689230769230768,103.29320526635196,GRIK3,Glutamate-Receptors,bioplanet
N-cadherin signaling events,1/34,4.3299673200093314E-2,5.1172341054655734E-2,0,0,24.170909090909092,75.887232515870664,GRIA2,Glutamate-Receptors,bioplanet
ERBB4 signaling events,1/38,4.8273621231532039E-2,5.5372683177345568E-2,0,0,21.553513513513515,65.325897756806043,GRIN2B,Glutamate-Receptors,bioplanet
Taste transduction,1/52,6.5487373538224466E-2,7.2971644799735835E-2,0,0,15.625882352941176,42.594560287369276,GRM4,Glutamate-Receptors,bioplanet
Ephrin receptor B forward pathway,1/60,7.5188978942214352E-2,8.1454727187398879E-2,0,0,13.501694915254237,34.939019325707278,GRIA1,Glutamate-Receptors,bioplanet
Myocyte adrenergic pathway,1/72,8.9560026597750808E-2,9.4401109116548143E-2,0,0,11.212957746478873,27.055142380240479,GRIN1,Glutamate-Receptors,bioplanet
Oncostatin M,1/311,0.33484321261489036,0.34365487610475592,0,0,2.5372903225806454,2.7760312732787877,GRIK2,Glutamate-Receptors,bioplanet
Interleukin-2 signaling pathway,1/847,0.67561113569261444,0.67561113569261444,0,0,0.90439716312056739,0.35464814340541434,GRIA2,Glutamate-Receptors,bioplanet
Pentose phosphate pathway,6/27,2.7901319252241942E-16,6.1382902354932272E-15,0,0,1901.9047619047619,68117.23752238194,RPIA;G6PD;RPE;TALDO1;TKT;PGD,HMP-Shunt-Glutathione,bioplanet
Carbohydrate metabolism,6/235,2.0134329068949032E-10,2.2147761975843937E-9,0,0,172.5938864628821,3853.3327921018458,RPIA;G6PD;RPE;TALDO1;TKT;PGD,HMP-Shunt-Glutathione,bioplanet
Glutathione metabolism,4/51,4.6794552389320608E-9,3.4316005085501775E-8,0,0,339.47234042553191,6511.1080511147711,G6PD;GPX1;GSR;PGD,HMP-Shunt-Glutathione,bioplanet
Metabolism,8/1615,1.4865748933755274E-8,8.1761619135654003E-8,0,0,91.519601742377105,1649.5681547883164,RPIA;G6PD;GPX1;RPE;GSR;TALDO1;TKT;PGD,HMP-Shunt-Glutathione,bioplanet
Free radical-induced apoptosis,2/10,8.0847637609619041E-6,3.5572960548232382E-5,0,0,713.67857142857144,8368.2589892095857,GPX1;GSR,HMP-Shunt-Glutathione,bioplanet
Sulfation biotransformation reaction,2/17,2.4394349832130377E-5,8.9445949384478051E-5,0,0,380.49523809523811,4041.3004289208102,G6PD;GSR,HMP-Shunt-Glutathione,bioplanet
Nucleotide metabolism,2/70,4.2786277535055014E-4,1.3447115796731575E-3,0,0,83.710084033613441,649.31468119392071,GPX1;GSR,HMP-Shunt-Glutathione,bioplanet
Integration of energy metabolism,2/125,1.3555434918531971E-3,3.7277446025962922E-3,0,0,46.150987224157959,304.76048109474726,TALDO1;TKT,HMP-Shunt-Glutathione,bioplanet
Purine catabolism,1/10,4.4918441075108293E-3,1.08680944304791E-2,0,0,277.52777777777777,1500.1741678966396,GPX1,HMP-Shunt-Glutathione,bioplanet
Cardiac protection against reactive oxygen species,1/11,4.9400429229450454E-3,1.08680944304791E-2,0,0,249.76249999999999,1326.3340991921912,GPX1,HMP-Shunt-Glutathione,bioplanet
Nucleotide di- and triphosphate biosynthesis and interconversion,1/18,8.0724193100501513E-3,1.6144838620100303E-2,0,0,146.86764705882354,707.79955270198946,GSR,HMP-Shunt-Glutathione,bioplanet
Oxidative stress,1/27,1.2086885938503104E-2,2.1961121811004677E-2,0,0,95.98557692307692,423.83719817033131,GSR,HMP-Shunt-Glutathione,bioplanet
Pentose and glucuronate interconversions,1/29,1.2977026524684581E-2,2.1961121811004677E-2,0,0,89.120535714285708,387.19082250922293,RPE,HMP-Shunt-Glutathione,bioplanet
Amyotrophic lateral sclerosis (ALS),1/53,2.3603252767760232E-2,3.6689613117505765E-2,0,0,47.93028846153846,179.56463060223416,GPX1,HMP-Shunt-Glutathione,bioplanet
Arachidonic acid metabolism,1/58,2.580420824342157E-2,3.6689613117505765E-2,0,0,43.714912280701753,159.87495051613905,GPX1,HMP-Shunt-Glutathione,bioplanet
Selenium pathway,1/60,2.6683354994549647E-2,3.6689613117505765E-2,0,0,42.228813559322035,153.02519848914329,GSR,HMP-Shunt-Glutathione,bioplanet
"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",1/135,5.914658048384825E-2,7.4372946104612328E-2,0,0,18.523320895522389,52.379070618835193,GPX1,HMP-Shunt-Glutathione,bioplanet
p53 signaling pathway,1/139,6.0850592267410082E-2,7.4372946104612328E-2,0,0,17.982789855072465,50.339830135348393,GPX1,HMP-Shunt-Glutathione,bioplanet
Purine metabolism,1/164,7.1438655209091761E-2,8.2718442873685197E-2,0,0,15.205521472392638,40.126096435870053,GPX1,HMP-Shunt-Glutathione,bioplanet
Metapathway biotransformation,1/174,7.564408105928605E-2,8.3208489165214658E-2,0,0,14.319364161849711,36.968532753958556,GSR,HMP-Shunt-Glutathione,bioplanet
Huntington's disease,1/184,7.9832568626939979E-2,8.3634119513937122E-2,0,0,13.530054644808743,34.201593194349968,GPX1,HMP-Shunt-Glutathione,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.22737553151715231,0.22737553151715231,0,0,4.3056294326241131,6.3772929565534495,G6PD,HMP-Shunt-Glutathione,bioplanet
Tricarboxylic acid (TCA) cycle,18/39,1.5247174148991575E-51,7.3186435915159554E-50,0,0,359298,42041469.993027285,FH;PDHA1;MDH1;MDH2;IDH1;IDH2;SDHC;SDHA;SDHB;CS;SUCLA2;OGDH;SUCLG2;SUCLG1;ACO1;ACO2;DLAT;DLD,TCA,bioplanet
Pyruvate metabolism and citric acid (TCA) cycle,16/40,3.0675423335709164E-43,7.362101600570199E-42,0,0,6652.666666666667,651231.41805153317,FH;PDHA1;MDH2;IDH1;IDH2;SDHC;SDHA;SDHB;CS;SUCLA2;OGDH;SUCLG2;SUCLG1;ACO2;DLAT;DLD,TCA,bioplanet
Tricarboxylic acid (TCA) cycle and respiratory electron transport,16/117,9.7693311381750653E-35,1.5630929821080104E-33,0,0,1574.7326732673268,123319.25296136606,FH;PDHA1;MDH2;IDH1;IDH2;SDHC;SDHA;SDHB;CS;SUCLA2;OGDH;SUCLG2;SUCLG1;ACO2;DLAT;DLD,TCA,bioplanet
Metabolism,18/1615,1.9506046138508775E-20,2.3407255366210531E-19,0,0,330930,15018782.33050645,FH;PDHA1;MDH1;MDH2;IDH1;IDH2;SDHC;SDHA;SDHB;CS;SUCLA2;OGDH;SUCLG2;SUCLG1;ACO1;ACO2;DLAT;DLD,TCA,bioplanet
Glyoxylate and dicarboxylate metabolism,5/16,1.3952971702381534E-12,1.3394852834286271E-11,0,0,698.28671328671328,19061.770435817718,CS;MDH1;MDH2;ACO1;ACO2,TCA,bioplanet
Pyruvate metabolism,5/52,8.1426793346065444E-10,6.5141434676852355E-9,0,0,163.1342062193126,3414.1920244920138,PDHA1;MDH1;MDH2;DLAT;DLD,TCA,bioplanet
Glycolysis and gluconeogenesis,5/75,5.3405584803241802E-9,3.6620972436508661E-8,0,0,109.4065934065934,2083.9697459835165,PDHA1;MDH1;MDH2;DLAT;DLD,TCA,bioplanet
Shuttle for transfer of acetyl groups from mitochondria to the cytosol,3/8,3.4176008683086065E-8,2.0505605209851637E-7,0,0,799.08,13737.577149046836,CS;PDHA1;MDH1,TCA,bioplanet
Electron transport reaction in mitochondria,3/10,7.3152815006368097E-8,3.9014834670062983E-7,0,0,570.71428571428567,9377.2439048737961,SDHC;SDHA;SDHB,TCA,bioplanet
Pyruvate dehydrogenase (PDH) complex regulation,3/12,1.3396387529464043E-7,6.4302660141427403E-7,0,0,443.84444444444443,7024.1470984676416,PDHA1;DLAT;DLD,TCA,bioplanet
Propanoate metabolism,3/33,3.2834133860106212E-6,1.4327622048046346E-5,0,0,133.01333333333332,1679.5097473860005,SUCLA2;SUCLG2;SUCLG1,TCA,bioplanet
Lysine catabolism,2/8,2.1351432280008236E-5,8.5405729120032945E-5,0,0,416.16666666666669,4475.619360309719,OGDH;DLD,TCA,bioplanet
"Respiratory electron transport, ATP biosynthesis by chemiosmotic coupling, and heat production by uncoupling proteins",3/81,4.9978381520491782E-5,1.8453556253720044E-4,0,0,51.035897435897439,505.45544613076794,SDHC;SDHA;SDHB,TCA,bioplanet
Electron transport chain,3/105,1.0833688709701263E-4,3.7144075576118612E-4,0,0,38.980392156862742,355.90130477266865,SDHC;SDHA;SDHB,TCA,bioplanet
Parkinson's disease,3/131,2.0852947952210106E-4,6.6729433447072339E-4,0,0,31.021875000000001,262.92373431613515,SDHC;SDHA;SDHB,TCA,bioplanet
Oxidative phosphorylation,3/136,2.3287274968603297E-4,6.9861824905809893E-4,0,0,29.84812030075188,249.68007529057198,SDHC;SDHA;SDHB,TCA,bioplanet
Gluconeogenesis,2/31,3.5027247768592E-4,9.890046428778919E-4,0,0,86.004310344827587,684.31902763532389,MDH1;MDH2,TCA,bioplanet
Alzheimer's disease,3/169,4.4054318457767433E-4,1.1747818255404647E-3,0,0,23.874698795180723,184.49178464758796,SDHC;SDHA;SDHB,TCA,bioplanet
Huntington's disease,3/184,5.6461195980898394E-4,1.4263881089911171E-3,0,0,21.879558011049724,163.64535048765396,SDHC;SDHA;SDHB,TCA,bioplanet
Glutathione metabolism,2/51,9.5024886028767346E-4,2.2576747467452337E-3,0,0,50.849489795918366,353.85075072456357,IDH1;IDH2,TCA,bioplanet
Mitochondrial protein import,2/52,9.8773270170103978E-4,2.2576747467452337E-3,0,0,49.83,344.82850534778163,CS;ACO2,TCA,bioplanet
Glucose metabolism,2/61,1.3566437662336027E-3,2.9599500354187693E-3,0,0,42.209745762711862,278.70003786815613,MDH1;MDH2,TCA,bioplanet
Peroxisome,2/78,2.2061757830017701E-3,4.6041929384384762E-3,0,0,32.74013157894737,200.25484053611478,IDH1;IDH2,TCA,bioplanet
Acetylcholine biosynthesis,1/7,6.2838777740325952E-3,1.256775554806519E-2,0,0,195.84313725490196,992.87927206115364,PDHA1,TCA,bioplanet
"Valine, leucine and isoleucine biosynthesis",1/11,9.8579216348164949E-3,1.8927209538847668E-2,0,0,117.48235294117647,542.70737038143443,PDHA1,TCA,bioplanet
Iron metabolism in placenta,1/12,1.0749534506708167E-2,1.9845294473922769E-2,0,0,106.79679144385027,484.09840988752489,ACO1,TCA,bioplanet
Amino acid metabolism,2/195,1.3058557941245752E-2,2.3215214117770226E-2,0,0,12.816709844559586,55.60288072596898,OGDH;DLD,TCA,bioplanet
Branched-chain amino acid catabolism,1/17,1.5196239191186837E-2,2.605069575632029E-2,0,0,73.404411764705884,307.32278683532309,DLD,TCA,bioplanet
Peroxisomal lipid metabolism,1/20,1.7855195476470426E-2,2.9553426995537257E-2,0,0,61.804953560371516,248.79341471282055,IDH1,TCA,bioplanet
Carbohydrate metabolism,2/235,1.8583853678379284E-2,2.9734165885406855E-2,0,0,10.594957081545065,42.225800504297247,MDH1;MDH2,TCA,bioplanet
Proximal tubule bicarbonate reclamation,1/23,2.0507371457078361E-2,3.1753349352895525E-2,0,0,53.36898395721925,207.44368622737056,MDH1,TCA,bioplanet
Butanoate metabolism,1/30,2.6669504600617941E-2,4.0004256900926911E-2,0,0,40.472616632860039,146.68225415832842,PDHA1,TCA,bioplanet
"Glycine, serine and threonine metabolism",1/32,2.8423378470110255E-2,4.1343095956524009E-2,0,0,37.857685009487668,134.79392621731594,DLD,TCA,bioplanet
Fatty acid beta oxidation,1/34,3.0174267482518016E-2,4.2598965857672498E-2,0,0,35.559714795008915,124.48623298308226,DLD,TCA,bioplanet
Latent infection of Homo sapiens with Mycobacterium tuberculosis,1/37,3.2795014804391599E-2,4.4976020303165623E-2,0,0,32.591503267973856,111.38077026649427,DLAT,TCA,bioplanet
Lysine degradation,1/44,3.8884106119434915E-2,5.0444245776564214E-2,0,0,27.276333789329687,88.570884468646753,OGDH,TCA,bioplanet
"Valine, leucine and isoleucine degradation",1/44,3.8884106119434915E-2,5.0444245776564214E-2,0,0,27.276333789329687,88.570884468646753,DLD,TCA,bioplanet
JNK/MAPK pathway,1/53,4.6659751461469688E-2,5.893863342501434E-2,0,0,22.54524886877828,69.098332178804668,DLD,TCA,bioplanet
Tryptophan metabolism,1/58,5.09538444953197E-2,6.2712423994239638E-2,0,0,20.562435500515996,61.210979038699676,OGDH,TCA,bioplanet
Protein metabolism,2/442,5.9056438893680653E-2,7.0867726672416781E-2,0,0,5.5517045454545455,15.707225045167542,CS;ACO2,TCA,bioplanet
Renal cell carcinoma,1/70,6.1185260316693364E-2,7.1631524273201977E-2,0,0,16.976129582267689,47.428742028663351,FH,TCA,bioplanet
TSH regulation of gene expression,1/97,8.3826359716664023E-2,9.5801553961901736E-2,0,0,12.185049019607844,30.206831147050188,FH,TCA,bioplanet
TGF-beta regulation of extracellular matrix,2/565,9.0512902251203314E-2,0.10103765832692463,0,0,4.3115008880994674,10.357358506620612,IDH2;ACO1,TCA,bioplanet
FSH regulation of apoptosis,1/263,0.2120900942230608,0.23137101187970266,0,0,4.4274809160305342,6.8658900050717966,IDH1,TCA,bioplanet
Pathways in cancer,1/325,0.25548958318098075,0.27252222205971277,0,0,3.5689905591866378,4.8701504402535623,FH,TCA,bioplanet
Lipid and lipoprotein metabolism,1/489,0.35966291235301379,0.37530043028140569,0,0,2.3498071359691419,2.4028846753362743,IDH1,TCA,bioplanet
T cell receptor regulation of apoptosis,1/603,0.42379188148377023,0.43280873002597808,0,0,1.893687707641196,1.625755116918673,CS,TCA,bioplanet
Disease,1/674,0.4606133350022113,0.4606133350022113,0,0,1.687702123940215,1.3083005105722754,DLAT,TCA,bioplanet
"Respiratory electron transport, ATP biosynthesis by chemiosmotic coupling, and heat production by uncoupling proteins",8/81,8.2830410778319549E-18,7.1245347044065574E-17,0,0,727.52511415525112,28615.25168418224,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Chemiosmotic coupling formation of ATP,6/13,8.9056683805081968E-18,7.1245347044065574E-17,0,0,3425.4857142857145,134484.0337504051,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;ATP5O,ETC,bioplanet
Electron transport chain,8/105,7.1577598551653767E-17,3.8174719227548674E-16,0,0,546.85910652920961,20329.897166115032,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Tricarboxylic acid (TCA) cycle and respiratory electron transport,8/117,1.7478670057965793E-16,6.9914680231863172E-16,0,0,486.36085626911313,17646.614069931769,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Parkinson's disease,8/131,4.4255639930465273E-16,1.4161804777748888E-15,0,0,430.69918699186991,15226.923449022803,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Oxidative phosphorylation,8/136,6.0168469933142805E-16,1.6044925315504747E-15,0,0,413.77083333333331,14501.342864214073,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Alzheimer's disease,8/169,3.5506985213086384E-15,8.1158823344197439E-15,0,0,328.41407867494826,10926.872383812277,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Huntington's disease,8/184,7.0947088466880447E-15,1.4189417693376089E-14,0,0,300.19696969696969,9780.2452963520664,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Metabolism,8/1615,2.3504389542987437E-7,4.1785581409755439E-7,0,0,30.503215100601533,465.58562697834469,ATP5B;ATP5E;ATP5D;ATP5A1;ATP5C1;UQCR10;ATP5O;SDHA,ETC,bioplanet
Electron transport reaction in mitochondria,2/10,1.2345191962977191E-5,1.9752307140763506E-5,0,0,555.02777777777783,6273.0593076335972,ATP5A1;SDHA,ETC,bioplanet
Mitochondrial protein import,2/52,3.5922676978951407E-4,5.225116651483841E-4,0,0,88.617777777777775,702.8769289105478,ATP5B;ATP5A1,ETC,bioplanet
Tricarboxylic acid (TCA) cycle,1/39,2.1247185233602552E-2,2.681421400882213E-2,0,0,52.502631578947366,202.21550533647789,SDHA,ETC,bioplanet
Pyruvate metabolism and citric acid (TCA) cycle,1/40,2.178654888216798E-2,2.681421400882213E-2,0,0,51.153846153846153,195.73827523435421,SDHA,ETC,bioplanet
Protein metabolism,2/442,2.3488327786283323E-2,2.6843803184323795E-2,0,0,9.8732323232323225,37.036979252362322,ATP5B;ATP5A1,ETC,bioplanet
T cell receptor regulation of apoptosis,2/603,4.1681376658134324E-2,4.3140824994698262E-2,0,0,7.1687927528193756,22.780278844586391,ATP5D;ATP5C1,ETC,bioplanet
Cardiac muscle contraction,1/80,4.3140824994698262E-2,4.3140824994698262E-2,0,0,25.202531645569621,79.218752651351863,UQCR10,ETC,bioplanet
Fatty acid biosynthesis,5/25,1.1130265032515442E-13,2.8938689084540151E-12,0,0,1664.3333333333333,49641.276986355348,OLAH;FASN;MCAT;ACACB;ACACA,FA-Synthesis,bioplanet
ChREBP activates metabolic gene expression,3/8,2.3497053794504525E-9,3.0546169932855879E-8,0,0,2398.44,47654.546526647704,FASN;ACACB;ACACA,FA-Synthesis,bioplanet
Metabolism,7/1615,1.6449246340393463E-7,1.4256013495007668E-6,0,0,80.02985074626865,1250.0983672664765,OLAH;FASN;PPT1;PPT2;MCAT;ACACB;ACACA,FA-Synthesis,bioplanet
AMPK signaling,3/68,2.0794874561975374E-6,1.3516668465283993E-5,0,0,183.94153846153847,2406.5787211670349,FASN;ACACB;ACACA,FA-Synthesis,bioplanet
Fatty acid elongation in mitochondria,2/8,3.9152037969490335E-6,2.0359059744134976E-5,0,0,1110.3333333333333,13824.364138043773,PPT1;PPT2,FA-Synthesis,bioplanet
Integration of energy metabolism,3/125,1.3044279656333349E-5,5.6525211844111181E-5,0,0,97.721311475409834,1099.0873096928335,FASN;ACACB;ACACA,FA-Synthesis,bioplanet
Fatty acyl-CoA biosynthesis,2/18,2.1351432280008236E-5,7.9305319897173449E-5,0,0,416.16666666666669,4475.619360309719,FASN;ACACA,FA-Synthesis,bioplanet
"Fatty acid, triacylglycerol, and ketone body metabolism",3/173,3.4501102557195138E-5,1.1212858331088419E-4,0,0,69.959999999999994,718.80536856701258,FASN;ACACB;ACACA,FA-Synthesis,bioplanet
Ghrelin pathway,2/25,4.1807234442575231E-5,1.2077645505632844E-4,0,0,289.40579710144925,2917.9169208177068,FASN;ACACA,FA-Synthesis,bioplanet
Propanoate metabolism,2/33,7.3463419114969304E-5,1.9100488969892018E-4,0,0,214.63440860215053,2043.0454763342129,ACACB;ACACA,FA-Synthesis,bioplanet
Triglyceride biosynthesis,2/38,9.7714514143369419E-5,2.3096157888432772E-4,0,0,184.77777777777777,1706.1383034595449,FASN;ACACA,FA-Synthesis,bioplanet
Insulin signaling pathway,3/277,1.3978702039220948E-4,3.0287187751645384E-4,0,0,43.178102189781022,383.22252129037446,FASN;ACACB;ACACA,FA-Synthesis,bioplanet
Pyruvate metabolism,2/52,1.8379456792760984E-4,3.6758913585521969E-4,0,0,132.94666666666666,1143.5662661624315,ACACB;ACACA,FA-Synthesis,bioplanet
Lipid and lipoprotein metabolism,3/489,7.4226740582058657E-4,1.3784966108096608E-3,0,0,24.081481481481482,173.52636320870431,FASN;ACACB;ACACA,FA-Synthesis,bioplanet
Lysosome,2/121,9.9249972197192559E-4,1.7203328514180044E-3,0,0,55.666666666666664,384.95079962128187,PPT1;PPT2,FA-Synthesis,bioplanet
Import of palmitoyl-CoA into the mitochondrial matrix,1/8,3.1960315919264243E-3,5.1935513368804396E-3,0,0,407.85714285714283,2343.4840743955892,ACACB,FA-Synthesis,bioplanet
Vitamin B5 (pantothenate) metabolism,1/11,4.3922443961630329E-3,6.3443530166799366E-3,0,0,285.45714285714286,1549.4370877511301,FASN,FA-Synthesis,bioplanet
Reversal of insulin resistance by leptin,1/11,4.3922443961630329E-3,6.3443530166799366E-3,0,0,285.45714285714286,1549.4370877511301,ACACA,FA-Synthesis,bioplanet
SREBF and miR-33 in cholesterol and lipid homeostasis,1/16,6.3831440708516521E-3,8.7348287285338392E-3,0,0,190.25714285714287,961.57757966873419,FASN,FA-Synthesis,bioplanet
Activated AMPK stimulation of fatty-acid oxidation in muscle,1/18,7.1785287204102037E-3,9.3320873365332659E-3,0,0,167.85714285714286,828.65378226443977,ACACB,FA-Synthesis,bioplanet
Delta Np63 pathway,1/47,1.8649185668920001E-2,2.3089467971043814E-2,0,0,61.944099378881987,246.65847982339551,FASN,FA-Synthesis,bioplanet
Metabolism of vitamins and cofactors,1/51,2.0222210774875234E-2,2.3898976370307096E-2,0,0,56.977142857142859,222.26633779925106,FASN,FA-Synthesis,bioplanet
Leptin signaling pathway,1/61,2.4145126293327844E-2,2.729449059245756E-2,0,0,47.457142857142856,176.71486865577202,ACACA,FA-Synthesis,bioplanet
Adipocytokine signaling pathway,1/67,2.6492273471440286E-2,2.869996292739364E-2,0,0,43.129870129870127,156.60033842612921,ACACB,FA-Synthesis,bioplanet
p73 transcription factor network,1/79,3.1171754372239124E-2,3.241862454712869E-2,0,0,36.472527472527474,126.49558455333695,FASN,FA-Synthesis,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.20490514518483627,0.20490514518483627,0,0,4.9209726443768993,7.8007657613944312,ACACB,FA-Synthesis,bioplanet
Mitochondrial fatty acid beta-oxidation,8/23,7.7219075309732869E-25,3.3204202383185137E-23,0,0,159816,8873074.7601671405,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,FA-Oxidation,bioplanet
Fatty acid beta oxidation,8/34,2.8599320165720318E-23,6.1488538356298684E-22,0,0,159728,8291266.3302334575,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,FA-Oxidation,bioplanet
Fatty acid metabolism,8/42,1.8593590591002756E-22,2.6650813180437284E-21,0,0,159664,7989050.1223953804,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,FA-Oxidation,bioplanet
"Fatty acid, triacylglycerol, and ketone body metabolism",8/173,2.6613783224163547E-17,2.8609816965975812E-16,0,0,158616,6053595.886400043,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,FA-Oxidation,bioplanet
Lipid and lipoprotein metabolism,8/489,1.2068688400261396E-13,1.03790720242248E-12,0,0,156088,4642927.6132241115,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,FA-Oxidation,bioplanet
Mitochondrial beta-oxidation of saturated fatty acids,4/8,7.3447652171120716E-13,5.2637484055969847E-12,0,0,4997,139614.27296891858,ACADVL;ECHS1;ACADL;ACADS,FA-Oxidation,bioplanet
PPAR signaling pathway,5/69,2.3417544244199048E-11,1.438506289286513E-10,0,0,518.95833333333337,12702.821089703522,CPT1A;CPT2;ACADL;ACSL1;ACSL3,FA-Oxidation,bioplanet
Metabolism,8/1615,1.7787832462925605E-9,9.5609599488225134E-9,0,0,147080,2963270.2194565972,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,FA-Oxidation,bioplanet
Activated AMPK stimulation of fatty-acid oxidation in muscle,3/18,3.4176008683086065E-8,1.6328537481918897E-7,0,0,799.08,13737.577149046836,CPT1A;CPT2;ACSL1,FA-Oxidation,bioplanet
Fatty acid biosynthesis,3/25,9.620457240600272E-8,4.1367966134581171E-7,0,0,544.63636363636363,8799.5747818751188,ECHS1;ACSL1;ACSL3,FA-Oxidation,bioplanet
Beta-oxidation of myristoyl-CoA to lauroyl-CoA,2/5,1.3991087462114677E-6,5.0134730072577593E-6,0,0,2221,29938.358472423224,ACADVL;ACADL,FA-Oxidation,bioplanet
Beta-oxidation of lauroyl-CoA to decanoyl-CoA,2/5,1.3991087462114677E-6,5.0134730072577593E-6,0,0,2221,29938.358472423224,ECHS1;ACADL,FA-Oxidation,bioplanet
Adipocytokine signaling pathway,3/67,1.9881177381481777E-6,6.5760817492593566E-6,0,0,186.82499999999999,2452.6988000710403,CPT1A;ACSL1;ACSL3,FA-Oxidation,bioplanet
Import of palmitoyl-CoA into the mitochondrial matrix,2/8,3.9152037969490335E-6,1.202526880491489E-5,0,0,1110.3333333333333,13824.364138043773,CPT1A;CPT2,FA-Oxidation,bioplanet
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha),3/112,9.3794557126589772E-6,2.6887773042955734E-5,0,0,109.44770642201834,1267.0748739505509,CPT1A;CPT2;ACSL1,FA-Oxidation,bioplanet
Fatty acyl-CoA biosynthesis,2/18,2.1351432280008236E-5,5.7381974252522134E-5,0,0,416.16666666666669,4475.619360309719,ACSL1;ACSL3,FA-Oxidation,bioplanet
Butanoate metabolism,2/30,6.0560078897239473E-5,1.5318137603419395E-4,0,0,237.66666666666666,2308.1888742091614,ECHS1;ACADS,FA-Oxidation,bioplanet
Triglyceride biosynthesis,2/38,9.7714514143369419E-5,2.3342911712027138E-4,0,0,184.77777777777777,1706.1383034595449,ACSL1;ACSL3,FA-Oxidation,bioplanet
"Valine, leucine and isoleucine degradation",2/44,1.313331865142055E-4,2.9544064529055835E-4,0,0,158.33333333333334,1415.1474004141428,ECHS1;ACADS,FA-Oxidation,bioplanet
HNF3B pathway,2/45,1.3741425362351551E-4,2.9544064529055835E-4,0,0,154.64341085271317,1375.1681463191144,CPT1A;ACADVL,FA-Oxidation,bioplanet
Peroxisome,2/78,4.1408229311365571E-4,8.4788279066129501E-4,0,0,87.350877192982452,680.41492594532428,ACSL1;ACSL3,FA-Oxidation,bioplanet
Mitochondrial beta-oxidation of unsaturated fatty acids,1/6,2.3978589692277472E-3,4.6867243489451425E-3,0,0,571.05714285714282,3445.2899826083253,ACADL,FA-Oxidation,bioplanet
Fatty acid elongation in mitochondria,1/8,3.1960315919264243E-3,5.9751894979494019E-3,0,0,407.85714285714283,2343.4840743955892,ECHS1,FA-Oxidation,bioplanet
Alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,1/11,4.3922443961630329E-3,7.5546603614004169E-3,0,0,285.45714285714286,1549.4370877511301,ACSL1,FA-Oxidation,bioplanet
Reversal of insulin resistance by leptin,1/11,4.3922443961630329E-3,7.5546603614004169E-3,0,0,285.45714285714286,1549.4370877511301,CPT1A,FA-Oxidation,bioplanet
Beta-alanine metabolism,1/22,8.7676277457428009E-3,1.4500307425651554E-2,0,0,135.85714285714286,643.51303491498368,ECHS1,FA-Oxidation,bioplanet
RORA activates circadian expression,1/27,1.0750872860949598E-2,1.7121760482253064E-2,0,0,109.7032967032967,497.25962914000377,CPT1A,FA-Oxidation,bioplanet
Propanoate metabolism,1/33,1.3126184702817524E-2,2.0158069365041199E-2,0,0,89.107142857142861,386.1142784895618,ECHS1,FA-Oxidation,bioplanet
Linoleic acid metabolism,1/35,1.3916845835577172E-2,2.0635323135510981E-2,0,0,83.857142857142861,358.46037529540138,ACSL1,FA-Oxidation,bioplanet
Lysine degradation,1/44,1.746796731842876E-2,2.5037419823081223E-2,0,0,66.275747508305642,268.2435666902731,ECHS1,FA-Oxidation,bioplanet
Activation of chaperones by IRE1 alpha,1/48,1.9042648937520508E-2,2.6413996913334899E-2,0,0,60.623100303951368,240.13259456270143,ACADVL,FA-Oxidation,bioplanet
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha,1/57,2.2577612257970867E-2,2.9930211431682355E-2,0,0,50.857142857142854,192.78907770536534,CPT1A,FA-Oxidation,bioplanet
Tryptophan metabolism,1/58,2.2969697145244598E-2,2.9930211431682355E-2,0,0,49.962406015037594,188.53710846919242,ECHS1,FA-Oxidation,bioplanet
Circadian rhythm,1/62,2.4536660972781548E-2,3.1031659465576664E-2,0,0,46.676814988290396,173.05834842078664,CPT1A,FA-Oxidation,bioplanet
AMPK signaling,1/68,2.6882984076400464E-2,3.3027666151006288E-2,0,0,42.484008528784649,153.63329523076956,CPT1A,FA-Oxidation,bioplanet
Unfolded protein response,1/79,3.1171754372239124E-2,3.7232928833507845E-2,0,0,36.472527472527474,126.49558455333695,ACADVL,FA-Oxidation,bioplanet
Leptin influence on immune response,1/110,4.3169441381931593E-2,5.0169891335758332E-2,0,0,26.05897771952818,81.893527348965407,CPT1A,FA-Oxidation,bioplanet
Diabetes pathways,1/137,5.3512913216514357E-2,6.0554086008160979E-2,0,0,20.857142857142858,61.066216244013823,ACADVL,FA-Oxidation,bioplanet
Interleukin-4 regulation of apoptosis,1/267,0.10195750503475176,0.11241468503831606,0,0,10.593984962406015,24.188177671180238,CPT2,FA-Oxidation,bioplanet
Oncostatin M,1/311,0.11785522323100128,0.12669436497332637,0,0,9.0700460829493093,19.394464388314972,ACSL3,FA-Oxidation,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.20490514518483627,0.21490051812068195,0,0,4.9209726443768993,7.8007657613944312,ACSL3,FA-Oxidation,bioplanet
Disease,1/674,0.23989273938890673,0.24560447127911877,0,0,4.1008278497134363,5.8541916444105837,ACADVL,FA-Oxidation,bioplanet
Interleukin-2 signaling pathway,1/847,0.29266050808423211,0.29266050808423211,0,0,3.2330293819655522,3.972559044556689,ACSL1,FA-Oxidation,bioplanet
Ketone body biosynthesis and degradation,4/9,2.8335880166734179E-13,7.6506876450182291E-12,0,0,7995.6,231009.37452439216,BDH2;HMGCS1;BDH1;HMGCS2,Ketosis,bioplanet
Butanoate metabolism,4/30,6.1535270461820595E-11,8.3072615123457802E-10,0,0,1536,36113.52668476737,BDH2;HMGCS1;BDH1;HMGCS2,Ketosis,bioplanet
"Valine, leucine and isoleucine degradation",4/44,3.0448453159159981E-10,2.7403607843243981E-9,0,0,997.7,21862.002307531991,ACAA2;HMGCS1;HMGCS2;ACAA1,Ketosis,bioplanet
Metabolism,6/1615,2.7484977971000683E-7,1.8552360130425462E-6,0,0,110310,1666457.7086091747,BDH2;ACAA2;HMGCS1;BDH1;HMGCS2;ACAA1,Ketosis,bioplanet
Ketone body metabolism,2/5,7.4966635810394549E-7,4.0481983337613058E-6,0,0,3331.8333333333335,46990.969827806068,BDH1;HMGCS2,Ketosis,bioplanet
Lipid and lipoprotein metabolism,4/489,5.0927395565633492E-6,2.291732800453507E-5,0,0,80.44948453608248,980.49375218706791,HMGCS1;BDH1;HMGCS2;ACAA1,Ketosis,bioplanet
Terpenoid backbone biosynthesis,2/15,7.861232298160098E-6,3.0321896007188949E-5,0,0,768.5,9032.6163800399045,HMGCS1;HMGCS2,Ketosis,bioplanet
"Fatty acid, triacylglycerol, and ketone body metabolism",3/173,1.2480118748135471E-5,4.2120400774957217E-5,0,0,116.61176470588235,1316.7070107775719,HMGCS1;BDH1;HMGCS2,Ketosis,bioplanet
Fatty acid metabolism,2/42,6.4231664405344546E-5,1.9269499321603365E-4,0,0,249.42500000000001,2407.7030802596514,ACAA2;ACAA1,Ketosis,bioplanet
HNF3B pathway,2/45,7.3825750705583897E-5,1.9932952690507652E-4,0,0,231.98837209302326,2207.0916614912107,HMGCS1;BDH1,Ketosis,bioplanet
PPAR signaling pathway,2/69,1.7438628883467062E-4,4.2803907259419152E-4,0,0,148.70895522388059,1286.9626419636907,HMGCS2;ACAA1,Ketosis,bioplanet
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha),2/112,4.5941337405240465E-4,1.0336800916179105E-3,0,0,90.381818181818176,694.63490065711869,HMGCS1;HMGCS2,Ketosis,bioplanet
Beta-oxidation of very long chain fatty acids,1/6,1.7988408901478401E-3,3.7360541564608989E-3,0,0,799.56,5053.7091475187217,ACAA1,Ketosis,bioplanet
Fatty acid elongation in mitochondria,1/8,2.3978589692277472E-3,4.3161461446099454E-3,0,0,571.05714285714282,3445.2899826083253,ACAA2,Ketosis,bioplanet
SREBP control of lipid biosynthesis,1/8,2.3978589692277472E-3,4.3161461446099454E-3,0,0,571.05714285714282,3445.2899826083253,HMGCS1,Ketosis,bioplanet
Alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,1/11,3.2958256764104633E-3,5.5617058289426568E-3,0,0,399.68,2284.2105915703851,ACAA1,Ketosis,bioplanet
SREBF and miR-33 in cholesterol and lipid homeostasis,1/16,4.7909422750142686E-3,7.6091436132579553E-3,0,0,266.38666666666666,1422.7786907214238,HMGCS1,Ketosis,bioplanet
Peroxisomal lipid metabolism,1/20,5.9856908667451705E-3,8.9301666304507817E-3,0,0,210.26315789473685,1076.2074808846232,ACAA1,Ketosis,bioplanet
Biosynthesis of unsaturated fatty acids,1/21,6.2841913325394393E-3,8.9301666304507817E-3,0,0,199.74,1012.6254955871668,ACAA1,Ketosis,bioplanet
Cholesterol biosynthesis,1/24,7.1792448741713026E-3,9.6138601844645254E-3,0,0,173.66086956521738,857.28748845676546,HMGCS1,Ketosis,bioplanet
Fatty acid biosynthesis,1/25,7.4774468101390743E-3,9.6138601844645254E-3,0,0,166.41666666666666,814.7533474976135,ACAA2,Ketosis,bioplanet
Endochondral ossification,1/66,1.9639651901829803E-2,2.4103209152245668E-2,0,0,61.32,241.0001522133395,HMGCS1,Ketosis,bioplanet
Myc repressed pathway,1/73,2.1703662747464179E-2,2.5478212790501432E-2,0,0,55.338888888888889,211.96312071821211,HMGCS2,Ketosis,bioplanet
Peroxisome,1/78,2.3175738337888063E-2,2.6072705630124069E-2,0,0,51.732467532467531,194.75459813850165,ACAA1,Ketosis,bioplanet
Oncostatin M,1/311,8.9757774410979985E-2,9.6938396363858384E-2,0,0,12.699354838709677,30.61358077948114,HMGCS1,Ketosis,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.1579885090436732,0.16406499016073758,0,0,6.8900709219858154,12.71378607340954,HMGCS1,Ketosis,bioplanet
Interleukin-2 signaling pathway,1/847,0.22869399361533069,0.22869399361533069,0,0,4.5267139479905438,6.6785799558017329,ACAA2,Ketosis,bioplanet
Amino acid metabolism,5/195,4.9819439251313996E-10,8.5054000702145489E-9,0,0,521.15789473684208,11163.218140591824,OAT;CKM;GOT2;CKB;AZIN1,Various-Metabolites,bioplanet
Arginine and proline metabolism,4/54,7.0878333918454581E-10,8.5054000702145489E-9,0,0,797.76,16806.785842524689,OAT;CKM;GOT2;CKB,Various-Metabolites,bioplanet
Urea cycle and metabolism of amino groups,3/20,1.7067267107713721E-8,1.3653813686170977E-7,0,0,1175.1176470588234,21018.275756672261,OAT;CKM;CKB,Various-Metabolites,bioplanet
Creatine metabolism,2/7,1.5738947571499837E-6,9.4433685428999019E-6,0,0,1998.9,26709.216394028259,CKM;CKB,Various-Metabolites,bioplanet
Amino acid biosynthesis and interconversion (transamination),2/16,8.9830804443484569E-6,4.3118786132872594E-5,0,0,713.57142857142856,8291.8196663431772,OAT;GOT2,Various-Metabolites,bioplanet
Metabolism,5/1615,1.9107313964759392E-5,7.6429255859037566E-5,0,0,57.093167701863351,620.34235188423656,OAT;CKM;GOT2;CKB;AZIN1,Various-Metabolites,bioplanet
TSH regulation of gene expression,2/97,3.4480635511841256E-4,1.1821932175488431E-3,0,0,104.73157894736842,834.9754024954899,CKM;CKB,Various-Metabolites,bioplanet
"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,1.4992198216206949E-3,4.4976594648620848E-3,0,0,999.5,6499.5590198897235,GOT2,Various-Metabolites,bioplanet
SARS coronavirus protease,1/7,2.0983872819732461E-3,5.5956994185953225E-3,0,0,666.26666666666665,4108.5908256912071,CKM,Various-Metabolites,bioplanet
Alanine and aspartate metabolism,1/12,3.5949984464796287E-3,8.6279962715511086E-3,0,0,363.32727272727271,2044.8828145385057,GOT2,Various-Metabolites,bioplanet
Phenylalanine metabolism,1/17,5.0897414535705718E-3,1.1104890444153973E-2,0,0,249.72499999999999,1318.6799159042428,GOT2,Various-Metabolites,bioplanet
Gluconeogenesis,1/31,9.2650922497144687E-3,1.7413557840922831E-2,0,0,133.09333333333333,623.07663464879147,GOT2,Various-Metabolites,bioplanet
"Alanine, aspartate and glutamate metabolism",1/32,9.5627722512654691E-3,1.7413557840922831E-2,0,0,128.79354838709676,598.87423689504419,GOT2,Various-Metabolites,bioplanet
Cysteine and methionine metabolism,1/34,1.0157908740538318E-2,1.7413557840922831E-2,0,0,120.97575757575757,555.21856489644506,GOT2,Various-Metabolites,bioplanet
Tyrosine metabolism,1/41,1.2238541027235605E-2,1.9581665643576968E-2,0,0,99.77,439.30379261496881,GOT2,Various-Metabolites,bioplanet
Diurnally regulated genes with circadian orthologs,1/48,1.4315528554342706E-2,2.147329283151406E-2,0,0,84.88085106382978,360.43893024633047,AZIN1,Various-Metabolites,bioplanet
Licensing factor removal from origins,1/61,1.8163138081236239E-2,2.3567582282195763E-2,0,0,66.446666666666673,266.34223514766154,AZIN1,Various-Metabolites,bioplanet
Glucose metabolism,1/61,1.8163138081236239E-2,2.3567582282195763E-2,0,0,66.446666666666673,266.34223514766154,GOT2,Various-Metabolites,bioplanet
Ubiquitin-mediated degradation of phosphorylated Cdc25A,1/64,1.9049268540735301E-2,2.3567582282195763E-2,0,0,63.273015873015872,250.60711544601855,AZIN1,Various-Metabolites,bioplanet
Retinoblastoma protein regulation,1/66,1.9639651901829803E-2,2.3567582282195763E-2,0,0,61.32,241.0001522133395,CKM,Various-Metabolites,bioplanet
Glycolysis and gluconeogenesis,1/75,2.2292714638201434E-2,2.5477388157944494E-2,0,0,53.837837837837839,204.77196596351359,GOT2,Various-Metabolites,bioplanet
Carbohydrate metabolism,1/235,6.846925989620635E-2,7.4693738068588741E-2,0,0,16.888888888888889,45.285366672402631,GOT2,Various-Metabolites,bioplanet
Oncostatin M,1/311,8.9757774410979985E-2,9.3660286341892149E-2,0,0,12.699354838709677,30.61358077948114,CKM,Various-Metabolites,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.1579885090436732,0.1579885090436732,0,0,6.8900709219858154,12.71378607340954,CKB,Various-Metabolites,bioplanet
Starch and sucrose metabolism,9/53,6.873598040887095E-22,8.3170536294733851E-20,0,0,1359.8181818181818,66262.830856734872,GYS2;GYS1;HK3;UGP2;GBE1;PGM2;HK2;PGM1;HK1,Glycogenesis,bioplanet
Glycogen biosynthesis,6/8,2.9087577948525759E-19,1.7597984658858086E-17,0,0,9993,426515.1367800546,GYS2;GYS1;UGP2;GBE1;PGM2;PGM1,Glycogenesis,bioplanet
Glycogen metabolism,7/36,2.5876616603653028E-17,1.0436902030140056E-15,0,0,963.53793103448277,36800.589148044754,GYS2;GSK3B;GYS1;GSK3A;UGP2;GBE1;PGM1,Glycogenesis,bioplanet
Carbohydrate metabolism,9/235,7.8095110139396159E-16,2.3623770817167337E-14,0,0,262.3274336283186,9125.3271261617811,GYS2;GYS1;HK3;UGP2;GBE1;PGM2;HK2;PGM1;HK1,Glycogenesis,bioplanet
Galactose metabolism,6/26,2.3814528284056434E-15,5.763115844741657E-14,0,0,998.4,33617.191956303795,HK3;UGP2;PGM2;HK2;PGM1;HK1,Glycogenesis,bioplanet
Amino sugar and nucleotide sugar metabolism,6/45,8.384867751691057E-14,1.6909483299243633E-12,0,0,511.5128205128205,15401.529632792603,HK3;UGP2;PGM2;HK2;PGM1;HK1,Glycogenesis,bioplanet
Glucose metabolism,6/61,5.6927972046558472E-13,9.8404065966193925E-12,0,0,362.41818181818184,10218.164809618886,GYS2;GYS1;UGP2;GBE1;PGM2;PGM1,Glycogenesis,bioplanet
Glucuronidation,5/27,2.3827105189100859E-12,3.6038496598515046E-11,0,0,648.2467532467532,17348.886800450167,UGP2;PGM2;PGM5;PGM1;HK1,Glycogenesis,bioplanet
Insulin signaling pathway,7/277,6.7643397265711611E-11,9.0942789657234499E-10,0,0,102.24148148148149,2394.1653961231518,GYS2;GSK3B;GYS1;HK3;GSK3A;HK2;HK1,Glycogenesis,bioplanet
Glycolysis and gluconeogenesis,5/75,5.0236909764937409E-10,6.0786660815574264E-9,0,0,203.24489795918367,4351.8159386678581,HK3;PGM2;HK2;PGM1;HK1,Glycogenesis,bioplanet
Metabolism,9/1615,2.5120009583992767E-8,2.7632010542392044E-7,0,0,34.337484433374847,600.89228083599858,GYS2;GYS1;HK3;UGP2;GBE1;PGM2;HK2;PGM1;HK1,Glycogenesis,bioplanet
Fructose and mannose metabolism,3/34,9.7713465122122907E-7,9.8527743998140596E-6,0,0,214.59139784946237,2969.6533966324346,HK3;HK2;HK1,Glycogenesis,bioplanet
Hexose transport,3/42,1.8695395169197152E-6,1.7401098580560427E-5,0,0,170.5042735042735,2248.9204048077477,HK3;HK2;HK1,Glycogenesis,bioplanet
Type 2 diabetes mellitus,3/50,3.183301843206519E-6,2.751282307342777E-5,0,0,141.42553191489361,1790.1066225817303,HK3;HK2;HK1,Glycogenesis,bioplanet
Fas signaling pathway in cardiomyocytes,2/7,6.9183362035045763E-6,5.5807912041603579E-5,0,0,799.32,9496.9888922401569,GSK3B;GSK3A,Glycogenesis,bioplanet
HIF-1 transcriptional activity in hypoxia,3/66,7.3920318600076983E-6,5.590224094130822E-5,0,0,105.42328042328042,1245.5874348034204,HK2;PGM1;HK1,Glycogenesis,bioplanet
AKT phosphorylation of cytosolic targets,2/14,2.9910033177640367E-5,2.0106188969413802E-4,0,0,332.93333333333334,3468.271932060884,GSK3B;GSK3A,Glycogenesis,bioplanet
Glycogen breakdown (glycogenolysis),2/14,2.9910033177640367E-5,2.0106188969413802E-4,0,0,332.93333333333334,3468.271932060884,PGM2;PGM1,Glycogenesis,bioplanet
Phosphoinositides and their downstream targets,2/25,9.8244631898203864E-5,6.256631820885614E-4,0,0,173.60869565217391,1602.0697145166423,GSK3B;GSK3A,Glycogenesis,bioplanet
Pentose phosphate pathway,2/27,1.148697562279265E-4,6.6186859540852882E-4,0,0,159.70400000000001,1448.7886335131677,PGM2;PGM1,Glycogenesis,bioplanet
Insulin regulation of blood glucose,2/27,1.148697562279265E-4,6.6186859540852882E-4,0,0,159.70400000000001,1448.7886335131677,GSK3B;GYS1,Glycogenesis,bioplanet
PIK3C1/AKT pathway,2/35,1.9420443968589212E-4,1.0681244182724067E-3,0,0,120.93939393939394,1033.6205203504062,GSK3B;GSK3A,Glycogenesis,bioplanet
PI3K/AKT activation,2/37,2.1723372076184829E-4,1.142838270094941E-3,0,0,114.01714285714286,961.68177925867292,GSK3B;GSK3A,Glycogenesis,bioplanet
GAB1 signalosome,2/39,2.4153608334790791E-4,1.217744420212369E-3,0,0,107.84324324324324,898.17155437421616,GSK3B;GSK3A,Glycogenesis,bioplanet
PI3K events in ERBB2 signaling,2/44,3.0784483010753261E-4,1.4899689777204579E-3,0,0,94.980952380952374,768.00787910486736,GSK3B;GSK3A,Glycogenesis,bioplanet
Interleukin-5 signaling pathway,2/49,3.8205410669454041E-4,1.7708418393294148E-3,0,0,84.855319148936175,667.80697627962684,GSK3B;GSK3A,Glycogenesis,bioplanet
SLC-mediated transmembrane transport,3/251,3.9514652613135699E-4,1.7708418393294148E-3,0,0,26.532258064516128,207.9135109890486,HK3;HK2;HK1,Glycogenesis,bioplanet
PI3K pathway,2/53,4.4708301876411925E-4,1.932037331087801E-3,0,0,78.184313725490199,603.01733667321537,GSK3B;GSK3A,Glycogenesis,bioplanet
PI3K cascade,2/57,5.1712223877973379E-4,2.157647961805096E-3,0,0,72.483636363636364,548.50043985409445,GSK3B;GSK3A,Glycogenesis,bioplanet
AMPK signaling,2/68,7.3539840870503494E-4,2.9661069151103074E-3,0,0,60.369696969696967,435.57328910015156,GYS2;GYS1,Glycogenesis,bioplanet
Signaling by SCF-KIT,2/78,9.662232834523858E-4,3.7713876547657639E-3,0,0,52.4,363.76685786814812,GSK3B;GSK3A,Glycogenesis,bioplanet
Signaling by ERBB4,2/93,1.369596559651751E-3,5.1787869911831836E-3,0,0,43.729670329670327,288.32017069600897,GSK3B;GSK3A,Glycogenesis,bioplanet
Downstream signaling events Of B cell receptor (BCR),2/98,1.5191345837264401E-3,5.5159646751408624E-3,0,0,41.44166666666667,268.94043920830592,GSK3B;GSK3A,Glycogenesis,bioplanet
Granule cell survival pathway,2/99,1.5499404872296638E-3,5.5159646751408624E-3,0,0,41.012371134020619,265.33112403993107,GSK3B;GSK3A,Glycogenesis,bioplanet
Signaling by ERBB2,2/102,1.6441492326284893E-3,5.6840587756584919E-3,0,0,39.776000000000003,254.98532927894865,GSK3B;GSK3A,Glycogenesis,bioplanet
Transmembrane transport of small molecules,3/432,1.9040935979923387E-3,6.3535552459115146E-3,0,0,15.197358197358197,95.192440026074081,HK3;HK2;HK1,Glycogenesis,bioplanet
Signaling by EGFR in cancer,2/111,1.9428226785018683E-3,6.3535552459115146E-3,0,0,36.475229357798163,227.7372298548145,GSK3B;GSK3A,Glycogenesis,bioplanet
Signaling by PDGF,2/122,2.3402979819493433E-3,7.4520014688386985E-3,0,0,33.113333333333337,200.58325555691616,GSK3B;GSK3A,Glycogenesis,bioplanet
Signaling by FGFR in disease,2/128,2.5720034529958381E-3,7.9798055849358059E-3,0,0,31.526984126984129,187.99761733894536,GSK3B;GSK3A,Glycogenesis,bioplanet
NGF signaling via TRKA from the plasma membrane,2/136,2.8971640392483618E-3,8.7639212187262932E-3,0,0,29.632835820895522,173.17497225422156,GSK3B;GSK3A,Glycogenesis,bioplanet
Signaling by the B cell receptor (BCR),2/151,3.5563006854602624E-3,1.0495423974163214E-2,0,0,26.629530201342281,150.16483706596762,GSK3B;GSK3A,Glycogenesis,bioplanet
Purine metabolism,2/164,4.1790832145389102E-3,1.2039739737124003E-2,0,0,24.476543209876542,134.07426448723129,PGM2;PGM1,Glycogenesis,bioplanet
Chemokine signaling pathway,2/189,5.5087461361039312E-3,1.5501355406245946E-2,0,0,21.17754010695187,110.15324345880153,GSK3B;GSK3A,Glycogenesis,bioplanet
Deregulation of CDK5 in Alzheimer's disease,1/10,5.9850935124877696E-3,1.6459007159341368E-2,0,0,201.8080808080808,1032.9512945731403,GSK3B,Glycogenesis,bioplanet
eIF2 regulation,1/11,6.5817961978748346E-3,1.7697718665396781E-2,0,0,181.61818181818182,912.34941820810161,GSK3B,Glycogenesis,bioplanet
Antigen-activated B-cell receptor generation of second messengers,2/211,6.8195026239272968E-3,1.793825690206963E-2,0,0,18.927272727272726,94.408644674929661,GSK3B;GSK3A,Glycogenesis,bioplanet
Signaling by NGF,2/221,7.4579519766788237E-3,1.9200259344215695E-2,0,0,18.053881278538814,88.436475920995093,GSK3B;GSK3A,Glycogenesis,bioplanet
Wnt signaling pathway,2/231,8.122658489695499E-3,2.0475868276107406E-2,0,0,17.256768558951965,83.058514409718541,GSK3B;GSK3A,Glycogenesis,bioplanet
Sonic Hedgehog (Shh) pathway,1/16,9.5603900128118108E-3,2.3136143831004582E-2,0,0,121.04848484848485,562.89079821946234,GSK3B,Glycogenesis,bioplanet
CRMPs in Sema3A signaling,1/16,9.5603900128118108E-3,2.3136143831004582E-2,0,0,121.04848484848485,562.89079821946234,GSK3B,Glycogenesis,bioplanet
Beta-catenin phosphorylation cascade,1/17,1.0155125895608219E-2,2.40935339876195E-2,0,0,113.47727272727273,520.83534082548363,GSK3B,Glycogenesis,bioplanet
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,1/20,1.1937370540334344E-2,2.7777342988085686E-2,0,0,95.545454545454547,423.08305184927309,GSK3B,Glycogenesis,bioplanet
C-Myc pathway,1/25,1.4901244370148439E-2,3.4019822052603045E-2,0,0,75.621212121212125,318.08630270790064,GSK3B,Glycogenesis,bioplanet
Segmentation clock,1/26,1.5493040473318351E-2,3.4715886986509639E-2,0,0,72.592727272727274,302.52034425805169,GSK3B,Glycogenesis,bioplanet
Glycolysis,1/27,1.6084510729761806E-2,3.5385923605475975E-2,0,0,69.7972027972028,288.25536568739051,HK1,Glycogenesis,bioplanet
Cell cycle: G1/S checkpoint,1/28,1.6675655297670511E-2,3.5399198088037397E-2,0,0,67.208754208754215,275.13956021760828,GSK3B,Glycogenesis,bioplanet
Multi-step regulation of transcription by PITX2,1/28,1.6675655297670511E-2,3.5399198088037397E-2,0,0,67.208754208754215,275.13956021760828,GSK3B,Glycogenesis,bioplanet
Pentose and glucuronate interconversions,1/29,1.7266474337105393E-2,3.5410904996436482E-2,0,0,64.805194805194802,263.04354416299202,UGP2,Glycogenesis,bioplanet
Reelin signaling pathway,1/29,1.7266474337105393E-2,3.5410904996436482E-2,0,0,64.805194805194802,263.04354416299202,GSK3B,Glycogenesis,bioplanet
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages,1/30,1.7856968008938604E-2,3.6011552151359517E-2,0,0,62.567398119122259,251.85639443535081,GSK3B,Glycogenesis,bioplanet
Interleukin-7 signaling pathway,1/35,2.0804561456238449E-2,4.12680645279484E-2,0,0,53.352941176470587,206.61369382894844,GSK3B,Glycogenesis,bioplanet
PI3K/PLC/TRK pathway,1/36,2.1393106288118857E-2,4.17510622719739E-2,0,0,51.825974025974027,199.25462501506232,GSK3B,Glycogenesis,bioplanet
ALK in cardiac myocytes,1/37,2.1981326879869451E-2,4.2218104007368314E-2,0,0,50.383838383838381,192.34342502593887,GSK3B,Glycogenesis,bioplanet
FOXM1 transcription factor network,1/41,2.4330970017212364E-2,4.5682214962759801E-2,0,0,45.336363636363636,168.47016546086343,GSK3A,Glycogenesis,bioplanet
TWEAK signaling pathway,1/42,2.4917571797868982E-2,4.5682214962759801E-2,0,0,44.228381374722836,163.29923491461832,GSK3B,Glycogenesis,bioplanet
BMP receptor signaling,1/42,2.4917571797868982E-2,4.5682214962759801E-2,0,0,44.228381374722836,163.29923491461832,GSK3B,Glycogenesis,bioplanet
Integrin-linked kinase signaling,1/45,2.6675438127783887E-2,4.7124360466225097E-2,0,0,41.206611570247937,149.33325716982057,GSK3B,Glycogenesis,bioplanet
LKB1 signaling events,1/47,2.7845734763739902E-2,4.7124360466225097E-2,0,0,39.411067193675891,141.13400615713857,GSK3B,Glycogenesis,bioplanet
Delta Np63 pathway,1/47,2.7845734763739902E-2,4.7124360466225097E-2,0,0,39.411067193675891,141.13400615713857,GSK3B,Glycogenesis,bioplanet
Activation of chaperones by IRE1 alpha,1/48,2.8430399289540761E-2,4.7124360466225097E-2,0,0,38.570599613152808,137.3227634294791,GSK3A,Glycogenesis,bioplanet
Presenilin action in Notch and Wnt signaling,1/48,2.8430399289540761E-2,4.7124360466225097E-2,0,0,38.570599613152808,137.3227634294791,GSK3B,Glycogenesis,bioplanet
Diurnally regulated genes with circadian orthologs,1/48,2.8430399289540761E-2,4.7124360466225097E-2,0,0,38.570599613152808,137.3227634294791,UGP2,Glycogenesis,bioplanet
Energy metabolism,1/48,2.8430399289540761E-2,4.7124360466225097E-2,0,0,38.570599613152808,137.3227634294791,GSK3B,Glycogenesis,bioplanet
Signaling events mediated by stem cell factor receptor (c-Kit),1/52,3.0765835877853052E-2,4.963554854960292E-2,0,0,35.538324420677363,123.7213609818225,GSK3B,Glycogenesis,bioplanet
Endometrial cancer,1/52,3.0765835877853052E-2,4.963554854960292E-2,0,0,35.538324420677363,123.7213609818225,GSK3B,Glycogenesis,bioplanet
Androgen receptor regulation of biosynthesis and transcription,1/53,3.1348890445829294E-2,4.9910733472965062E-2,0,0,34.853146853146853,120.68168393395273,GSK3B,Glycogenesis,bioplanet
Basal cell carcinoma,1/55,3.2514035214057754E-2,5.0438439242320367E-2,0,0,33.558922558922561,114.97566851206538,GSK3B,Glycogenesis,bioplanet
Calcineurin-dependent NFAT signaling role in lymphocytes,1/55,3.2514035214057754E-2,5.0438439242320367E-2,0,0,33.558922558922561,114.97566851206538,GSK3B,Glycogenesis,bioplanet
Colorectal cancer,1/62,3.6581932884295822E-2,5.6030555430377139E-2,0,0,29.697466467958272,98.245182252874329,GSK3B,Glycogenesis,bioplanet
LPA receptor mediated events,1/65,3.8320513395665175E-2,5.7959776510943577E-2,0,0,28.301136363636363,92.311795529856738,GSK3B,Glycogenesis,bioplanet
Semaphorin interactions,1/66,3.8899400851019943E-2,5.8108981518190286E-2,0,0,27.864335664335666,90.469268293855038,GSK3B,Glycogenesis,bioplanet
NFAT involvement in hypertrophy of the heart,1/69,4.0634147279785517E-2,5.8796221378138447E-2,0,0,26.63101604278075,85.303045825353649,GSK3B,Glycogenesis,bioplanet
Hedgehog signaling pathway,1/70,4.1211757984317837E-2,5.8796221378138447E-2,0,0,26.243741765480895,83.692123770432559,GSK3B,Glycogenesis,bioplanet
CDC42 signaling events,1/70,4.1211757984317837E-2,5.8796221378138447E-2,0,0,26.243741765480895,83.692123770432559,GSK3B,Glycogenesis,bioplanet
Phase II of biological oxidations: conjugation,1/71,4.1789049905123193E-2,5.8796221378138447E-2,0,0,25.867532467532467,82.132543945907258,UGP2,Glycogenesis,bioplanet
Interleukin-6 signaling pathway,1/71,4.1789049905123193E-2,5.8796221378138447E-2,0,0,25.867532467532467,82.132543945907258,GSK3B,Glycogenesis,bioplanet
Degradation of beta-catenin by the destruction complex,1/73,4.2942678013426154E-2,5.9724874018673157E-2,0,0,25.146464646464647,79.15828251915687,GSK3B,Glycogenesis,bioplanet
Prolactin activation of MAPK signaling,1/75,4.4095032883891661E-2,6.0630670215351033E-2,0,0,24.464373464373466,76.363294371177119,GSK3B,Glycogenesis,bioplanet
Unfolded protein response,1/79,4.6395928037110373E-2,6.3077610027981512E-2,0,0,23.205128205128204,71.25235746632562,GSK3A,Glycogenesis,bioplanet
ATM-dependent DNA damage response,1/82,4.8118266638402123E-2,6.3981431464248978E-2,0,0,22.342312008978677,67.788661634410843,GSK3B,Glycogenesis,bioplanet
Regular glucocorticoid receptor pathway,1/82,4.8118266638402123E-2,6.3981431464248978E-2,0,0,22.342312008978677,67.788661634410843,GSK3B,Glycogenesis,bioplanet
Adaptive immune system,2/606,4.9478888846694387E-2,6.4842668338133472E-2,0,0,6.4185430463576161,19.295483081619231,GSK3B;GSK3A,Glycogenesis,bioplanet
MicroRNAs in cardiomyocyte hypertrophy,1/85,4.9837753350796807E-2,6.4842668338133472E-2,0,0,21.541125541125542,64.601458156557385,GSK3B,Glycogenesis,bioplanet
"Androgen receptor signaling, proteolysis, and transcription regulation",1/88,5.1554392476265073E-2,6.6362569038596525E-2,0,0,20.795193312434691,61.660199177576288,GSK3B,Glycogenesis,bioplanet
Prostate cancer,1/89,5.212597345862037E-2,6.6392029352558571E-2,0,0,20.557851239669422,60.729782313110633,GSK3B,Glycogenesis,bioplanet
Neural crest differentiation,1/91,5.3268188288120896E-2,6.7140112321485715E-2,0,0,20.098989898989899,58.938598932853118,GSK3B,Glycogenesis,bioplanet
ERBB signaling pathway,1/94,5.4979145063769622E-2,6.8582232502228085E-2,0,0,19.44770283479961,56.41392256593172,GSK3B,Glycogenesis,bioplanet
Wnt signaling pathway and pluripotency,1/98,5.7256011863196878E-2,7.0674318376772655E-2,0,0,18.64198687910028,53.32023276493544,GSK3B,Glycogenesis,bioplanet
Senescence and autophagy,1/99,5.7824442308268532E-2,7.0674318376772655E-2,0,0,18.450834879406308,52.591221242131901,GSK3B,Glycogenesis,bioplanet
Melanogenesis,1/101,5.8960360820228652E-2,7.1342036592476663E-2,0,0,18.079999999999998,51.182489597636589,GSK3B,Glycogenesis,bioplanet
Disease,2/674,5.984968951189143E-2,7.1701113177612505E-2,0,0,5.7488095238095234,16.188182165321187,GSK3B;GSK3A,Glycogenesis,bioplanet
p53 activity regulation,1/118,6.8565105440893517E-2,8.1337036846550151E-2,0,0,15.439782439782439,41.378177533334416,GSK3B,Glycogenesis,bioplanet
Notch signaling pathway,1/121,7.0250702466731596E-2,8.2527524257034204E-2,0,0,15.051515151515151,39.97208258305033,GSK3B,Glycogenesis,bioplanet
Neurotrophin signaling pathway,1/126,7.3053818341985266E-2,8.4995307878655946E-2,0,0,14.445818181818181,37.798333725467877,GSK3B,Glycogenesis,bioplanet
Diabetes pathways,1/137,7.9193425149914884E-2,9.0812992535743042E-2,0,0,13.270053475935828,33.651024339520887,GSK3A,Glycogenesis,bioplanet
T cell receptor signaling pathway,1/139,8.0305704143177725E-2,9.0812992535743042E-2,0,0,13.076416337285902,32.977605605491178,GSK3B,Glycogenesis,bioplanet
Biological oxidations,1/139,8.0305704143177725E-2,9.0812992535743042E-2,0,0,13.076416337285902,32.977605605491178,UGP2,Glycogenesis,bioplanet
Integrated breast cancer pathway,1/152,8.750554999553678E-2,9.8038625457962505E-2,0,0,11.94280553883203,29.093307967223456,GSK3A,Glycogenesis,bioplanet
Alzheimer's disease,1/169,9.6842775909610629E-2,0.10750436591800813,0,0,10.725108225108226,25.039550693443655,GSK3B,Glycogenesis,bioplanet
Immune system,2/998,0.11791989045636402,0.12971187950200042,0,0,3.8136546184738958,8.1526393197593663,GSK3B;GSK3A,Glycogenesis,bioplanet
Signal transduction,2/1020,0.12228578298023829,0.13330252018566516,0,0,3.7269155206286837,7.8317197402722583,GSK3B;GSK3A,Glycogenesis,bioplanet
Focal adhesion,1/233,0.13121467280799082,0.14175870901577578,0,0,7.7413793103448274,15.722126507086697,GSK3B,Glycogenesis,bioplanet
BDNF signaling pathway,1/261,0.14587182547128588,0.15593083289490509,0,0,6.8979020979020982,13.278647441002503,GBE1,Glycogenesis,bioplanet
FSH regulation of apoptosis,1/263,0.14691004090924942,0.15593083289490509,0,0,6.8445523941707149,13.1274055429777,HK2,Glycogenesis,bioplanet
Oncostatin M,1/311,0.1714828156607924,0.18042974517352939,0,0,5.7706744868035189,10.175269999538838,HK2,Glycogenesis,bioplanet
Pathways in cancer,1/325,0.17852665887288219,0.18463013438990383,0,0,5.5173961840628509,9.5065692939544437,GSK3B,Glycogenesis,bioplanet
Axon guidance,1/325,0.17852665887288219,0.18463013438990383,0,0,5.5173961840628509,9.5065692939544437,GSK3B,Glycogenesis,bioplanet
Developmental biology,1/420,0.22489275794183788,0.23061037043188459,0,0,4.2458233890214796,6.3353273392188054,GSK3B,Glycogenesis,bioplanet
Cell cycle,1/453,0.24042888624055422,0.24446970785804251,0,0,3.9292035398230087,5.6004153138431203,GSK3B,Glycogenesis,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.29105390803880499,0.29347935727246166,0,0,3.1308833010960671,3.8642826265936581,GSK3A,Glycogenesis,bioplanet
T cell receptor regulation of apoptosis,1/603,0.30751465442285902,0.30751465442285902,0,0,2.9275143461189974,3.4522201671691719,GYS1,Glycogenesis,bioplanet
Starch and sucrose metabolism,7/53,2.176946892698341E-17,5.4423672317458527E-16,0,0,1517.554347826087,58222.525306338546,PYGB;G6PC2;G6PC;PGM2;PYGM;PYGL;PGM1,Glycogenolysis,bioplanet
Carbohydrate metabolism,8/235,2.8721724232465877E-15,3.5902155290582349E-14,0,0,696.52863436123346,23322.361204302666,PYGB;G6PC2;G6PC;G6PC3;PGM2;PYGM;PYGL;PGM1,Glycogenolysis,bioplanet
Glycogen breakdown (glycogenolysis),5/14,9.4452898627987421E-15,7.8710748856656196E-14,0,0,2775.2777777777778,89622.767418594027,PYGB;PGM2;PYGM;PYGL;PGM1,Glycogenolysis,bioplanet
Glucose metabolism,5/61,2.7854295586870667E-11,1.7408934741794167E-10,0,0,444.97767857142856,10814.75259424178,PYGB;PGM2;PYGM;PYGL;PGM1,Glycogenolysis,bioplanet
Galactose metabolism,4/26,2.8133315273480518E-10,1.4066657636740259E-9,0,0,726.14545454545453,15969.01436766058,G6PC2;G6PC;PGM2;PGM1,Glycogenolysis,bioplanet
Glycogen metabolism,4/36,1.1063035843581148E-9,4.609598268158812E-9,0,0,498.97500000000002,10289.982943950805,PYGB;PYGM;PYGL;PGM1,Glycogenolysis,bioplanet
Glycolysis and gluconeogenesis,4/75,2.265107375482483E-8,8.0896691981517259E-8,0,0,224.45070422535213,3951.0188947443371,G6PC2;G6PC;PGM2;PGM1,Glycogenolysis,bioplanet
Insulin signaling pathway,5/277,5.9185842983755613E-8,1.849557593242363E-7,0,0,90.62040441176471,1508.1576438230959,PYGB;G6PC2;G6PC;PYGM;PYGL,Glycogenolysis,bioplanet
Glucuronidation,3/27,1.832884740960949E-7,5.091346502669303E-7,0,0,415.97916666666669,6452.7539277277237,PGM2;PGM5;PGM1,Glycogenolysis,bioplanet
Hexose transport,3/42,7.1695557771327255E-7,1.7923889442831814E-6,0,0,255.7948717948718,3619.0502947040868,G6PC2;G6PC;G6PC3,Glycogenolysis,bioplanet
Glycogen biosynthesis,2/8,5.0328413188770481E-6,1.1438275724720565E-5,0,0,951.66666666666663,11609.882108963659,PGM2;PGM1,Glycogenolysis,bioplanet
G alpha s pathway,3/120,1.723404001719666E-5,3.5904250035826381E-5,0,0,84.931623931623932,931.58305363978468,PYGB;PYGM;PYGL,Glycogenolysis,bioplanet
Pentose phosphate pathway,2/27,6.2812729266017238E-5,1.2079371012695623E-4,0,0,228.18285714285713,2207.7496479850938,PGM2;PGM1,Glycogenolysis,bioplanet
SLC-mediated transmembrane transport,3/251,1.5514452393491996E-4,2.7704379274092849E-4,0,0,39.804435483870968,349.13081213664407,G6PC2;G6PC;G6PC3,Glycogenolysis,bioplanet
Amino sugar and nucleotide sugar metabolism,2/45,1.7642278783867052E-4,2.9403797973111755E-4,0,0,132.54485049833886,1145.5357354354971,PGM2;PGM1,Glycogenolysis,bioplanet
Metabolism,5/1615,3.2607353199595604E-4,5.0948989374368129E-4,0,0,14.270962732919255,114.57282086955985,G6PC2;G6PC;G6PC3;PGM2;PGM1,Glycogenolysis,bioplanet
Adipocytokine signaling pathway,2/67,3.9199458726740105E-4,5.7646262833441339E-4,0,0,87.586813186813188,687.05395647589478,G6PC2;G6PC,Glycogenolysis,bioplanet
Transmembrane transport of small molecules,3/432,7.6298796329304973E-4,1.0597055045736801E-3,0,0,22.799533799533801,163.66117078052136,G6PC2;G6PC;G6PC3,Glycogenolysis,bioplanet
Purine metabolism,2/164,2.31663232637735E-3,3.0482004294438815E-3,0,0,34.971781305114639,212.19620469407434,PGM2;PGM1,Glycogenolysis,bioplanet
HNF3B pathway,1/45,2.0072530463390581E-2,2.5090663079238226E-2,0,0,56.667613636363633,221.47987353276542,G6PC,Glycogenolysis,bioplanet
FoxO family signaling,1/49,2.1839307484116888E-2,2.5999175576329629E-2,0,0,51.934895833333336,198.60131834764672,G6PC,Glycogenolysis,bioplanet
PI3K pathway,1/53,2.3603252767760232E-2,2.6821878145182085E-2,0,0,47.93028846153846,179.56463060223416,G6PC,Glycogenolysis,bioplanet
HIF-1 transcriptional activity in hypoxia,1/66,2.9316565848365818E-2,3.1865832443875884E-2,0,0,38.319230769230771,135.25165407819361,PGM1,Glycogenolysis,bioplanet
ATM-dependent DNA damage response,1/82,3.6307532410312794E-2,3.7820346260742495E-2,0,0,30.72530864197531,101.87682930785095,G6PC,Glycogenolysis,bioplanet
TNF-alpha signaling pathway,1/101,4.4551152729863527E-2,4.4551152729863527E-2,0,0,24.86375,77.354041535408541,PYGL,Glycogenolysis,bioplanet
Urea cycle,6/9,2.6447403387171765E-20,5.8184287451777884E-19,0,0,19989,901086.70898147044,ARG2;CPS1;ARG1;ASL;ASS1;OTC,Urea-Cycle,bioplanet
Arginine and proline metabolism,7/54,5.5688482082349826E-18,6.1257330290584811E-17,0,0,2970.5319148936169,118017.2826053364,ARG2;CPS1;ARG1;ASL;ASS1;OTC;AGMAT,Urea-Cycle,bioplanet
Urea cycle and metabolism of amino groups,6/20,1.2195074783804719E-17,8.9430548414567942E-17,0,0,4281,166725.68340192657,ARG2;CPS1;ARG1;ASL;ASS1;OTC,Urea-Cycle,bioplanet
Amino acid metabolism,7/195,5.9634760443834913E-14,3.2799118244109204E-13,0,0,737.38297872340422,22453.708238619871,ARG2;CPS1;ARG1;ASL;ASS1;OTC;AGMAT,Urea-Cycle,bioplanet
"Alanine, aspartate and glutamate metabolism",4/32,3.7591924050842833E-10,1.6540446582370848E-9,0,0,713,15473.274155202571,CPS1;CAD;ASL;ASS1,Urea-Cycle,bioplanet
Metabolism,8/1615,1.7787832462925605E-9,6.5222052364060548E-9,0,0,147080,2963270.2194565972,ARG2;CPS1;ARG1;CAD;ASL;ASS1;OTC;AGMAT,Urea-Cycle,bioplanet
Alanine and aspartate metabolism,2/12,9.2214027460096553E-6,2.8981551487458916E-5,0,0,666.06666666666672,7722.3658701781433,ASL;ASS1,Urea-Cycle,bioplanet
Amoebiasis,2/105,7.4882016164342909E-4,2.0592554445194298E-3,0,0,64.36569579288026,463.24066620795458,ARG2;ARG1,Urea-Cycle,bioplanet
Pyrimidine biosynthesis,1/6,2.3978589692277472E-3,5.8614330358900488E-3,0,0,571.05714285714282,3445.2899826083253,CAD,Urea-Cycle,bioplanet
Polyamine metabolism,1/14,5.5872022837974E-3,1.2291845024354282E-2,0,0,219.54945054945054,1138.8637280375192,AGMAT,Urea-Cycle,bioplanet
Nitrogen metabolism,1/23,9.1645547457302242E-3,1.8329109491460448E-2,0,0,129.67532467532467,608.49004713317277,CPS1,Urea-Cycle,bioplanet
ATF2 transcription factor network,1/59,2.3361644422266112E-2,4.28296814408212E-2,0,0,49.098522167487687,184.44644096582132,ARG1,Urea-Cycle,bioplanet
Nucleotide metabolism,1/70,2.7663993715122369E-2,4.6815989364053241E-2,0,0,41.248447204968947,147.9839017165653,CAD,Urea-Cycle,bioplanet
Mitochondrial pathway of apoptosis: caspases,1/77,3.0393210313471041E-2,4.7760759064025923E-2,0,0,37.436090225563909,130.78433041717327,CAD,Urea-Cycle,bioplanet
Myc active pathway,1/85,3.3504105816256062E-2,4.9139355197175556E-2,0,0,33.857142857142854,114.98181239681574,CAD,Urea-Cycle,bioplanet
Pyrimidine metabolism,1/100,3.931350415205654E-2,5.2874421412636513E-2,0,0,28.705627705627705,92.896785007163814,CAD,Urea-Cycle,bioplanet
Interleukin-4 signaling pathway,1/104,4.0857507455219121E-2,5.2874421412636513E-2,0,0,27.585298196948681,88.208534104831983,ARG1,Urea-Cycle,bioplanet
Fas signaling pathway,1/115,4.5092326824716263E-2,5.5112843896875437E-2,0,0,24.909774436090224,77.196466677971443,CAD,Urea-Cycle,bioplanet
EGFR1 pathway,1/152,5.9216903867949332E-2,6.8566941320783434E-2,0,0,18.771050141911068,53.057278732945683,CAD,Urea-Cycle,bioplanet
Interleukin-4 regulation of apoptosis,1/267,0.10195750503475176,0.11215325553822694,0,0,10.593984962406015,24.188177671180238,ARG1,Urea-Cycle,bioplanet
TGF-beta regulation of extracellular matrix,1/565,0.20490514518483627,0.21466253305078087,0,0,4.9209726443768993,7.8007657613944312,CAD,Urea-Cycle,bioplanet
T cell receptor regulation of apoptosis,1/603,0.2172593427429915,0.2172593427429915,0,0,4.6013289036544851,7.0246809401958297,ARG2,Urea-Cycle,bioplanet
